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Abstract 
 
Crohn’s disease (CD) is a chronic inflammatory bowel disease, primarily affecting the 
young, which causes marked morbidity and reduced quality of life. Currently there is 
no cure for CD, and the causes of this disease are poorly understood.  
 
In ruminants, Johne’s disease (JD) is characterised by chronic intestinal inflammation 
similar to CD and is caused by the pathogen Mycobacterium avium subspecies 
paratuberculosis (MAP), which invades and replicates within the phagocytes of 
infected animals, leading to chronic disease. There is increasing molecular and 
microbiological evidence of Map bacteria in CD patients. However, little is known 
regarding the role of Map in the aetiology of CD.  
 
This thesis demonstrated that a human isolate of Map traffics through THP-1 human 
monocytes via a similar path to that taken by pathogenic mycobacteria. Flow 
cytometry demonstrated that Map are phagocytosed via a cholesterol-dependant 
mechanism, potentially mediated by a cell wall constituent. Once internalised, live 
Map reside in cholesterol-rich areas of the cell. These compartments exhibit reduced 
acidity compared to the compartments containing killed-Map, and have atypical 
retention of markers including the late endosomal marker Rab 7 and cellular TACO 
protein. Both of these markers were also present on phagosomes of pathogenic 
mycobacteria, where they interrupt fusion of the compartment with lysosomes. This 
was confirmed by visualisation of these proteins on phagosomes containing M. bovis, 
a known mycobacterial pathogen. 
 
Cholesterol depletion using simvastatin affected Map persistence in THP-1 cells at 1 
and 2 weeks post infection, a finding similar to other studies with M. tuberculosis. 
Spheroplast-like forms were evident after long term culture of Map with THP-1 
monocytes, visualised by light and electron microscopy. These were similar to forms 
observed in peripheral blood leukocytes from a CD patient. 
  
Collectively, these results support the hypothesis that Map may be involved in the 
aetiology of at least a subset of CD cases. 
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Chapter 1. Introduction 
 
1.1 Crohn’s disease 
 
Crohn’s disease (CD) is a chronic, inflammatory bowel disease that is increasing in 
frequency in developed countries (Shanahan, 2002). In New Zealand, the Canterbury 
region has one of the highest described rates of CD in the world, with approximately 
155 people of every 100,000 affected (Gearry et al., 2006). CD can occur at any age, 
but tends to disproportionately affect the young (Polito et al., 1996), leading to a 
marked morbidity and reduced quality of life. Symptoms include, but are not limited 
to, chronic inflammation of the gastro-intestinal (GI) tract, abdominal pain, (bloody) 
diarrhoea, vomiting, weight loss as well as extra-intestinal manifestations such as 
rashes, arthritis and ocular inflammation. Currently, there is no known cure. 
Treatment is limited to therapy for inflammation and corrective surgery to repair 
fistulae and/or remove severely diseased sections of intestine and bowel tissue 
(Baumgart and Sandborn, 2007).  
 
The initiating factors for CD are currently unknown. It is thought that the 
inflammation found in Crohn’s patients is due to an overactive, innate and adaptive 
immune response in genetically susceptible individuals. Enteric microflora are 
thought to contribute to the initiation, maintenance and/or relapse of the disease in 
at least a subset of cases (El-Zaatari et al., 2001; Goyette et al., 2007). Various 
microbes such as Adherent invasive Escherichia. coli (AIEC), Stenotrophomonas 
maltophilia, and Epstein Barr virus  are implicated in the aetiology of CD (Carvalho et 
al., 2009; Knosel et al., 2009; Lapaquette et al., 2009), but the most well studied 
(and controversial) is Mycobacterium avium subspecies paratuberculosis. 
 
1.2 Mycobacteria 
 
Mycobacteria are a group of species belonging to the family Mycobacteriaceae, in the 
Corynebacterinae sub-group of the Actinomycete line (Guenin-Mace et al., 2009). 
Although most species of mycobacteria are classed as saprophytic (Chacon et al., 
2004), several significant animal and human pathogens exist. The oldest and most 
well publicised mycobacterial diseases still cause significant morbidity and mortality. 
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Mycobacterium tuberculosis is thought to infect one third of the human population, 
and cause 2-3 million deaths per year from pulmonary tuberculosis (TB) (Jozefowski 
et al., 2008). Leprosy, also known as Hansen’s disease, is caused by Mycobacterium 
leprae that persists inside non-myelinated schwann cells, causing nerve damage and 
skin lesions. Unlike TB, the prevalence of leprosy has been significantly reduced in 
recent years due to the World Health Organisation’s eradication program (Worobec, 
2009). Other mycobacterial species that cause human disease include M. avium 
(pulmonary infection), M. marinum (granulomatous skin disease) and M. ulcerans 
(Buruli ulcer) (Torrado et al., 2007; Watt, 1995; Yamazaki et al., 2006).  
 
1.3 Mycobacterium avium subspecies paratuberculosis 
 
Mycobacterium avium subspecies paratuberculosis (Map) is one of the most 
fastidious and slow-growing species in the genus Mycobacterium. Map is classified as 
part of the Mycobacterium avium complex (MAC), composed of M. avium avium, M. 
avium silvaticum, and M. avium paratuberculosis. Map is typically differentiated from 
other MAC species by its dependence on an iron source (mycobactin J) for culture 
(Lilenbaum et al., 2007; Watt, 1995), and the presence of the genetic insertion 
element IS900 (van der Giessen et al., 1994). Map strains include “types” isolated 
from different animals (e.g. ‘sheep type’ or ‘cattle type’). These are differentiated by 
culture and DNA typing (Collins et al., 2002; Favila-Humara et al., 2010). However, 
strains isolated from bovine and ovine sources in the same region are more closely 
related to each other than strains from the same host species in different regions, 
suggesting local strain adaptation to multiple animal hosts in an area (Motiwala et al., 
2003). 
 
Map is an obligate intracellular pathogen, with a thick, lipid-rich cell wall (Figure 1.1). 
This high concentration of lipids confers resistance to desiccation, temperature 
fluctuations, acidic or alkaline conditions, chemical disinfectants, as well as many 
antibiotics (Lilenbaum et al., 2007). In addition, other cell wall constituents, such as 
mycolic acids (which make up 30-60% by dry weight) contribute to virulence 
(Guenin-Mace et al., 2009). 
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Figure 1.1. Transmission micrograph of Map bacilli. (A) Cross and (B) longitudinal 
sections of Map bacteria, showing the thick cell wall (arrows) characteristic of mycobacteria. 
Scale bar indicates 250 nm. Images adapted from Hines and Styer (2003). 
 
 
The complexity of the mycobacterial cell wall differs greatly from that of other micro-
organisms (Figure 1.2) (Collins et al., 1990), making cell division more complex and 
time consuming than in “normal” Gram positive or Gram negative bacteria. This leads 
to a longer division time and therefore a much slower growth rate than most other 
bacteria (Hett and Rubin, 2008).  
 
A B 
 4
 
Figure 1.2. Bacterial cell walls. A comparison of the cell walls of three classes of micro-
organisms with Gram positive (left), Gram negative (middle) and mycobacteria (right). Figure 
adapted from University of Cape Town website (http://web.uct.ac.za). 
 
 
Because of its thick cell wall, Map is able to survive in the environment for extended 
periods of time. The bacillary form has been shown to survive for five months in 
clear water, nine months in shallow water, and 11 months in bovine faeces. Map can 
also survive for up to 47 months in dry soil and at -14ºC for at least one year. Some 
 
 
 
 
 
 
 
 
 
 
 
The lipid bilayer cell 
membrane of most of 
the Gram-positive 
bacteria is covered by 
a porous 
peptidoglycan layer 
which does not 
exclude most 
antimicrobial agents.  
Gram-negative 
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surrounded by two 
membranes.  
The outer membrane 
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efficient permeability 
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 5
studies suggest that Map can survive for even longer in acidic soils (Collins et al., 
1990).  
 
1.4 Map and Johne’s disease 
 
Map is the causative agent of Johne’s disease, a chronic enteritis leading to wasting, 
diarrhoea and eventually death of infected animals. Johne and Frothingham initially 
reported Johne’s disease in the late 1800’s. However, it was not until 1910 that Trowt 
proved Map’s involvement by growing Map in the laboratory and inducing disease in 
experimentally-infected cattle, thus successfully fulfilling Koch’s postulates (reviewed 
in Harris and Barletta, 2001).(Harris and Barletta, 2001)  
 
Map enters the body via the faecal-oral route, moves across the intestinal epithelium 
then gains access into professional phagocytes, predominantly macrophages. From 
here it is able to persist, replicate and contribute to the disease phenotype (Valentin-
Weigand and Goethe, 1999). Ruminants are severely affected (Figure 1.3) with fecal 
shedding of Map, development of granulomatous lesions in the ileum and draining 
lymph nodes, as well as infertility characterizing this disease in these animals (Feola 
et al., 1999). Map infection has a severe effect on the dairy economy. In the USA, 
Johne’s positive herds experience an annual economic loss of approximately $100 per 
cow due to loss of milk production and cow replacement costs (Ott et al., 1999).  
 
 
 
Figure 1.3. Cow with Johne’s disease. An animal with end-stage Johne’s disease, 
exhibiting characteristic wasting. Image adapted from www.johnes.org.  
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1.5 Linking Map and Crohn’s disease 
 
In addition to causing widespread illness in bovine and other ruminant populations, 
Map can cause intestinal disease in a wide variety of other non-ruminant animals 
including at least 4 species of sub-human primates (Hines and Styer, 2003; 
Lilenbaum et al., 2007). 
 
The similarities between the gross pathology and histology of Johne’s disease in 
ruminants, and CD in humans initiated debate concerning the role of Map in CD 
(Goswami et al., 2000). Mucosal cobblestoning and the characteristic creeping 
mesenteric fat found in CD are also found in pathological specimens of Johne’s 
diseased animals (Figure 1.4). Many researchers have suggested that this similarity is 
indicative of Map involvement in CD (Chamberlin et al., 2001; Chiodini, 1989; 
Elsaghier et al., 1992; Greenstein, 2003). 
 
 
 
Figure 1.4. Mucosal cobblestoning and creeping mesenteric fat characteristic of 
Johne’s and Crohn’s diseased tissue. Mucosal cobblestoning (left) and creeping 
mesenteric fat (right) in tissue typical of Johne’s disease (top) and Crohn’s disease (bottom).  
Images adapted from Blowey et al., 1997 (top left), www.johnes.org (top right), Rosai, 2004 
(bottom left), and  Schaffler et al., 2005 (bottom right). (Blowey et al., 1997; Rosai, 2004; 
Schaffler et al., 2005). 
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Many different studies have used molecular and microbiological tools to demonstrate 
Map in CD patient serum, diseased tissue and breast milk (Bentley et al., 2008; 
Chiodini et al., 1984; Moss et al., 1992; Naser et al., 2000; Olsen et al., 2009; Sechi 
et al., 2004). However, there are also many studies that have found no genetic, 
serological or culture evidence of Map in tissue or blood samples taken from patients 
with CD (Cho et al., 1986; Heatley et al., 1975; Sasikala et al., 2009). This failure to 
consistently isolate Map from Crohn’s disease patients, as well as studies that report 
the presence of Map in the blood of healthy individuals (Abubakar et al., 2008; Juste 
et al., 2008), leaves uncertainty surrounding the role of Map in CD. Despite this 
anomaly, several anti-mycobacterial drug trials have successfully decreased disease 
activity and/or increased remission in CD patients.  However, the overall results from 
these trials have been mixed (Emery and Whittington, 2004; Gui et al., 1997).   
 
1.6 Mycobacterial entry into host cells 
 
Fundamental to mycobacterial involvement in animal and human disease is the ability 
for these bacteria to invade and survive within cells. Pathways of entry have been 
intensively characterised for many pathogens (Aderem and Underhill, 1999). 
However, how mycobacteria enter host cells is a subject of intensive research and 
debate. Considerable variation, within and among species, suggests that pathogenic 
mycobacteria enter cells via several different pathways (Darnelishvilli et al., 2007). 
 
Some pathogenic bacterial species such as Fim-H Escherichia coli (E. coli) and 
Bordetella pertussis enter macrophages via pathways that fail to stimulate an 
oxidative burst (Baorto et al., 1997). Whether mycobacteria modify the phagocytic 
process in this way remains largely unknown but beads coated with mycobacterial 
mannose from both pathogenic and non-pathogenic mycobacterial strains bypass 
activation of NADPH oxidase (the respiratory burst) and exhibit attenuated fusion 
with lysosomes in human macrophages (Dequcker et al., 1999). This suggests that 
some mycobacteria may possess cell wall components that aid intracellular survival. 
However, it remains unclear whether mycobacteria are phagocytosed via a normal 
pathway, then persist by affecting phagosome-lysosome fusion once inside the cell, 
or whether they exploit a pathway of entry into the cell that results in them residing 
in a compartment that is unlikely to fuse with lysosomes (Rosenberger et al., 2000). 
Mycobacterial uptake into macrophages was originally thought to be mediated solely 
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by complement and mannose receptors (Darnelishvilli et al., 2007). More recently, 
however, other receptors (including the transferrin and scavenger receptors) have 
been shown to be equally important, suggesting mycobacterial uptake may involve 
several alternate pathways (Bermudez and Sangari, 2001). M. avium subspecies 
avium grown in macrophages uses a different mechanism to gain entry to cells than 
those grown on laboratory media, suggesting the development of an intracellular 
phenotype may affect uptake (Bermudez et al., 2004). Mycobacterial ligands 
implicated in uptake include cell wall proteins such as the mannans (common on 
mycobacterial cell walls) as well as other less well defined proteins including a 35 
kDa major membrane protein reportedly involved in bacterial internalisation into 
bovine epithelial cells (Bannatine et al., 2003). 
 
Evidence is also emerging of an essential role for cholesterol in the phagocytosis of 
pathogenic organisms, including mycobacteria. Cholesterol-enriched plasma 
membrane domains (lipid rafts) are thought to play a significant role in mycobacterial 
entry. Depletion of plasma membrane cholesterol specifically inhibits cellular uptake 
of Mycobacterium bovis, M. tuberculosis and M. kansasii into phagocytic cells (Kaul et 
al., 2004; Pandey and Sassetti, 2008).  In addition, cholesterol aggregation is shown 
to occur at the site of mycobacterial internalisation (Gatfield and Pieters, 2000). 
Depletion of cellular cholesterol stimulates phagosomal maturation (de Chastellier 
and Thilo, 2006) and decreases survival of pathogenic mycobacteria (Pandey and 
Sassetti, 2008). Conversely, increased cholesterol increases susceptibility to, and 
severity of mycobacterial infection (Martens et al., 2008).  
 
1.7 Mycobacterial survival inside phagocytic cells 
 
Typically, a bacterium is taken up by the cell and deposited into a phagosome. This 
compartment sequentially fuses with early and late endosomes, and then finally 
lysosomes. As more lysosomes fuse with the maturing phagosome, the phagosomal 
pH drops dramatically, and the bacterium is killed (Beron et al., 2002; Desjardins et 
al., 1994b).  
 
Many intracellular pathogens, including mycobacteria, halt the progression of the 
phagocytic process at the early endosomal stage. This modified compartment fails to 
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fuse with lysosomes (Kelley and Schorey, 2003; Sun et al., 2007), and is conducive to 
mycobacterial persistence and/or replication (Gomes et al., 1999).  
 
Pathogenic mycobacteria such as M. bovis and M. tuberculosis reside in phagosomes 
that acquire markers of early endosomes, but fail to fuse with late endosomal and 
lysosmal organelles. The lack of fusion of mycobacterium containing vacuoles with 
end stage organelles (e.g. lysosomes) is attributed to a failure of the intermediate 
molecules responsible for docking and fusion of endosomes to the mycobacteria-
containing compartment (Clemens et al., 2000b). Consistent with this hypothesis, M. 
bovis secretes a factor that binds a late endosomal molecule (Rab 7) integral for 
phagosome-lysosome fusion, switching it from an active (GTP bound) to an inactive 
(GDP bound) form. By impairing Rab 7 function, further maturation of the M. bovis 
phagosome is compromised (Sun et al., 2007). 
 
Once phagocytosed, many virulent mycobacteria remain associated with cholesterol-
rich membranes (de Chastellier and Thilo, 2006; Pandey and Sassetti, 2008). It has 
been proposed that close association with cholesterol-rich areas of the cell allow 
intracellular mycobacteria to acquire host cholesterol as a carbon energy source 
(Pandey and Sassetti, 2008) and thus permit them to remain metabolically active in 
their cellular microenvironment. However, other benefits of residing in a cholesterol-
rich compartment have recently been documented. Cholesterol-rich membranes are 
more recalcitrant to fusion with lysosomes than membranes with normal levels of 
cholesterol (Huynh et al., 2008). In addition, cholesterol mediates the association of 
a protein integral for mycobacterial persistence. 
 
The recruitment of the TACO (Tryptophan-aspartate-containing-coat) protein to the 
phagosomal membrane prevents phagosome maturation and/or fusion with 
lysosomes (Gatfield and Pieters, 2000). TACO is anchored to the mycobacterium-
containing phagosomal membrane in a cholesterol-dependent manner. Increased 
phagosomal cholesterol has been shown to prolong its normally transient association 
with the early phagosome (Ferrari et al., 1999). Cellular cholesterol depletion with 
agents such as methyl-β-cyclodextrin (MβCD) mitigates this effect, and results in 
greater clearance of mycobacteria from infected cells (de Chastellier and Thilo, 2006; 
Deghmane et al., 2007). Thus, association with cholesterol-rich areas of the cell is 
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thought to prolong intracellular mycobacterial survival. To date, however, a role for 
cholesterol in Map infection has not been demonstrated 
 
1.8 Thesis aims 
 
The aim of this thesis was to analyse whether cell membrane-associated cholesterol 
has a role in the uptake and intra-cellular survival of Map in human monocytes. 
Specifically, Map bacteria were tracked through THP-1 monocytes using markers of 
early and late endosomes, and phagosomal acidity. The dependence of phagocytosis 
and trafficking on cholesterol was measured using depletion and co-localisation 
studies. Finally, the effect of cholesterol depletion on survival of Map was 
investigated, and long term persistence of these bacteria was assessed using light 
and electron microscopy.  
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Chapter 2. Materials & Methods 
 
2.1 Introduction 
 
The experiments described in the results chapters of this thesis (Chapters 3 through 
5) utilise a series of methods that were adapted and optimised for studying Map and 
THP-1 cells. The development of these methods is described in this chapter. 
 
2.2 Bacterial strains and culture 
 
Two different mycobacterial strains were used in this study. Mycobacterium avium 
subsp. paratuberculosis (Map) strain Dominic (ATCC 43545) was originally obtained 
from the intestinal tissue of a Crohn’s Disease patient(Chiodini et al., 1984). Since its 
isolation, this strain has been used in a variety of studies as a representative human 
Map isolate(Greenstein et al., 2007a; Jaravata et al., 2007). M. bovis Bacillus 
Calmette Guerin (BCG) (ATCC 19210) is the cause of bovine tuberculosis but is also 
known to jump the species barrier and cause tuberculosis in humans(O'Reilly and 
Daborn, 1995).  M. bovis reportedly survives in human leukocytes following uptake 
via a cholesterol-dependent pathway(Gatfield and Pieters, 2000), and was used as a 
positive control for these experiments. Strains were sub-cultured from stocks held at 
the University of Otago, Christchurch.  
 
Mycobacterial strains were cultured in Middlebrook 7H9 media broth supplemented 
with OADC (oleic acid dextrose catalase; Becton Dickinson, Sparks, MD, USA), 0.05% 
Tween-80 (Sigma, St Louis, MO, USA) and 2 μg/ml mycobactin J (Allied Monitor, 
Fayette, MO, USA), as previously described(Chiodini et al., 1984; Feola et al., 1999; 
Shin and Collins, 2008). This medium supports the growth of human and ruminant-
derived strains of Map(Shin and Collins, 2008; Sung and Collins, 1998). Cultures took 
15 days to reach late-exponential growth phase (Figure 2.1) and were maintained at 
this level by regular passage into fresh medium. 
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Figure 2.1. Absorbance values for culture of bacillary Map. Initial growth of Map in 
Middlebrook 7H9 media. Bacteria were grown to late log phase before being used for 
experimentation (approximately 16 days). To quantitate bacterial numbers, 100 μl of bacterial 
suspension in PBS was aliquoted into a 96 well plate and absorbance was measured at 
600 nm. Values were blanked using bacteria-free PBS (phosphate buffered saline).  
 
 
E. coli strain BL21 (ATCC BAA-1025) has been used in previous mycobacterial studies 
(Gatfield and Pieters 2000) and provided an additional control for these experiments. 
Each strain was maintained on blood agar plates (Fort Richard, Auckland, NZ) and 
transferred to Brucella broth (BD Biosciences, Sparks MD, USA) with (H. pylori) and 
without (E. coli) the addition of 5% foetal bovine serum (FBS; Gibco, Auckland, NZ).  
Broth cultures were incubated with constant rotation (100 rpm) at 37oC in a CO2 
(10%) incubator.    
 
Map, M. bovis BCG and H. pylori are classified as bio-safety level 2 (BSL-2) (ATCC), 
while E. coli strain BL21 is designated level 1 (ATCC). As such, all bacterial 
manipulations were conducted in a biological safety hood, and all experiments were 
conducted under BSL-2/PC2 conditions.  
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2.2.1 Enumeration of bacteria 
 
Map and M. bovis growth were quantified using a standardised spectrophotometric 
method (D Glubb, submitted). One hundred microlitres of bacterial solution (in PBS) 
was read at 600 nm to give the optical density (OD) (Figure 2.2). For experimental 
procedures, the OD of Map and M. bovis suspensions was enumerated and the 
solution diluted to give a working concentration of approximately 100 million 
bacteria/ml. 
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Figure 2.2. Enumeration of Map and M. bovis bacteria. The graph relates optical 
density of a 100 μl bacterial solution to bacterial CFUs/ml. Data from unpublished work of D. 
Glubb. 
 
 
E. coli strain BL21 was enumerated by direct counting of a dilution series using a 
haemocytometer. 
 
2.2.2 Bacterial labelling  
 
Visualising bacteria for flow cytometry and fluorescent microscopy requires a label 
that is non-toxic, and not washed out during incubations with cells. Additionally, the 
label must demonstrate negligible interaction with the processes being studied, or 
with bacterial or cellular constituents such as ligands or receptors.   
 
Fluorescein isothiocyanate (FITC) is a functionalised derivative of fluorescein that is 
reactive towards nucleophiles such as the amine and sulfhydryl groups on proteins 
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with which it forms covalent bonds(Hermanson, 2008).  FITC permanently labels 
both bacteria (Pikaar et al., 1995) and mycobacteria (Kudo et al., 2004; Schuller et 
al., 2001) with minimal effects on bacterial survival and bacteria-cell interactions. It 
is also applicable to fluorescence microscopy and flow cytometry(Baorto et al., 1997; 
Marques et al., 2001), exciting with blue light, and fluorescing green (488 and 530 
nm respectively).   
 
Labelling the bacteria for these experiments required a FITC concentration that was 
high enough to give a reliable signal by both flow cytometry and fluorescent 
microscopy for at least 48 hours post treatment, and to ensure that even a single 
bacterium inside a cell could be clearly identified. To achieve this, 1 ml aliquots of 
bacteria were pelleted by centrifugation (10,000 rpm, 5 min) and the supernatant 
removed. The bacteria were then resuspended in 200 μl of 100 μg/ml FITC solution 
for 1 h at 37oC in the dark. Following labelling, the bacteria were washed three times 
with PBS (10,000 rpm, 5 min), before being resuspended in PBS (Figure 2.3).  
 
 
Figure 2.3. FITC-labelled Map.  Map bacteria were labelled with 100 μg/ml FITC. Green 
fluorescence was imaged using blue light excitation. Scale bar indicates 10μm.  
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To ensure that labelling Map with 100 μg/ml FITC had no significant effect on 
bacterial viability, labelled and unlabelled Map were serially diluted and plated on 
Middlebrook 7H9 agar. Colonies were counted after 6 weeks. Results showed no 
observable effect on Map viability (Figure 2.4). Confirming this observation, in a 
related study, M. bovis labelled with a similar concentration of FITC did not show 
reduced viability(Schuller et al., 2001). 
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Figure 2.4. Comparative viability of labelled and unlabelled MAP cultures. The 
viability of Map incubated with 100 μg/ml FITC for 1 h was compared with that of unlabelled 
bacteria. Values are mean +/- SEM of three independent experiments. There was no 
significant difference in viability between the two treatments at any dilution (data analysed by 
2-way ANOVA).  
 
 
2.2.3 Killing bacteria  
 
Mycobacteria are more tolerant to temperature and chemical stresses than many 
other pathogenic bacteria, exemplified by their ability to survive some pasteurisation 
techniques(Sung and Collins, 1998). It is thought this resistance is predominately 
due to their large and complex cell wall (Figure 1.4) and slow replication time (Figure 
2.1). Heat treatment is a well established procedure for killing Map and other 
mycobacteria. Map in volumes less than 10 ml are killed after treatment at 72oC for 
25 seconds(Le Cabec et al., 2000; Yakes et al., 2008). For heat inactivation in the 
following experiments, a temperature and time well above the upper survival limit of 
Map (85oC, 15 min) was used to ensure that all bacteria were killed. This protocol 
was also used to kill E. coli BL21, confirmed by no growth at 24 h when 50 μl of 
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bacterial suspension was plated onto blood agar. E. coli grow rapidly in RPMI media, 
therefore they were killed in these experiments to enable their use as a control at 48 
h post infection. 
 
Formaldehyde fixation, which reportedly kills Map in 5 minutes(Lilenbaum et al., 
2007), was also used to treat Map, thereby overcoming the potentially confounding 
release of cytoplasmic contents from heat-killed bacteria. Additionally, formaldehyde 
treatment has the advantage of retaining an intact bacterial unit with similar 
antigenic presentation to a live bacterium for live/dead comparison experiments(Smit 
et al., 1974).   
 
The viability of Map after 30 minutes incubation with 4% formaldehyde was tested 
by plating serially diluted bacteria on Middlebrook 7H9 agar and incubating the 
cultures for 6 weeks. This confirmed a loss of over 99.99% of viable bacteria when 
compared with Map incubated in PBS alone (data not shown). While mutants of MAP 
strain 43545 that were unable to persist in human cells would have been the ideal 
controls for these experiments, they do not exist for this strain. Therefore heat and 
formaldehyde killed MAP were used as in similar studies (Rumsey et al., 2006). 
 
2.2.4 Generation of single bacterial cell suspensions  
 
Mycobacteria are notorious for their ability to form clumps in culture. In nature, this 
behaviour may contribute to their resistance to heat and other stresses(Rowe et al., 
2000). However, in culture, this ability to aggregate interferes with experimental 
doses and can inhibit growth(Lewin et al., 2008). There are several well- 
characterised methods to eliminate clumps and generate single mycobacteria in 
culture. Of these, the two that are predominantly used are sonication and passage 
through a 25 gauge needle(Parish and Stoker, 1998). 
 
These two methods were compared to establish the most efficient way to generate 
single Map in solution. Bacterial suspensions were treated, then visualised by light 
microscopy using Ziehl Neelsen staining, an acid-fast stain that is specific for 
mycobacteria (Appendix 1). Light microscopy showed the optimum method for 
generating a suspension of single Map was sonication (Omniruptor 4000) of the 
bacterial suspension for 10 seconds, at 10% power with a 50% pulse (Figure 2.5).  
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This is in contrast to passage through a 25 gauge needle, which failed to remove 
many of the clumps (Figure 2.6).  
 
 
 
Figure 2.5. Map bacteria after sonication. Images show Map before (A) and after 
sonication for 10 (B), 20 (C), and 30 (D) seconds. The sonicator was set to 10% power with 
a 50% pulse (Omniruptor 4000 ultrasonic homogeniser). Scale bar indicates 10μm. 
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Figure 2.6. Map bacteria after passage through a 25 gauge needle. Images show a 
solution of Map before (A) and after passage through a 25 gauge needle 5 times (B), 10 
times (C) or 20 times (D). The control in (A) is the same control as in figure 2.5. Scale bar 
indicates 10μm. 
 
 
It was also important to ascertain whether the bacteria would stay homogenous 
during the course of an experiment, given the potential of reclumping to significantly 
affect experiments involving the cellular uptake of mycobacteria(Cougoule et al., 
2002; Parish and Stoker, 1998). To analyse the extent and timeframe of re-clumping, 
Map bacteria (50 million/ml) were suspended in Middlebrook 7H9 medium. The 
solution was sonicated and a loopful was taken at time 0, 2 h, 4 h, 6 h and 24 h, 
spread onto a microscope slide, and Ziehl-Nelson stained. Relative bacterial clumping 
was analysed by light microscopy. There was no observable increase in the amount 
of clumped mycobacteria up to the 6 hour stage (Figure 2.7). A slight increase in 
bacterial clumping occurred at 24 hours post-sonication (Figure 2.8). However the 
majority of mycobacteria in suspension remained singular at this time point and this 
level of clumping was judged to be acceptable for experimentation. Reclumping was 
significantly decreased in the formaldehyde-treated bacterial cultures (Figure 2.8D). 
A B
C D
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Figure 2.7. Map bacteria 6 h after sonication.  Map bacteria before (A) and immediately 
after (B) sonication. The same bacteria 2 hours (C) and 6 hours (D) post-sonication. Scale bar 
indicates 10μm. 
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Figure 2.8. Map bacteria 24 h after sonication.  A suspension of Map bacteria before 
(A) and immediately after (B) sonication. The same bacteria 24 hours post-sonication (C) and 
formaldehyde killed bacteria at 24 hours (D). Scale bar indicates 10 μm. 
 
 
2.2.5 Simvastatin and growth of Map 
 
Before examining the effect on cholesterol on Map uptake and persistence, it was 
first necessary to ensure that co-culture of these bacteria with simvastatin had no 
effect on Map growth. To test this, duplicate 2 ml aliquots (100 million bacteria/ml) 
with and without the addition of simvastatin (2.5 ug/ml) were grown in capped 5 ml 
tubes at 37oC. Relative growth was assessed over a 7 day period (Figure 2.9). No 
significant difference was observed between treated and untreated Map (data 
analysed by one way ANOVA). 
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Figure 2.9. Map growth with and without 2.5 μg/ml simvastatin. Values are mean 
+/- SEM of three independent experiments. No significant difference was found between 
cultures with or without 2.5 μg/ml simvastatin (data analysed by one way ANOVA).  
 
 
2.3 Cell culture of THP-1 human monocytes 
 
THP-1 monocytes are a non-adhesive, phagocytic cell line originally derived from the 
peripheral blood of a 1 year old human male with acute monocytic 
leukemia(Tsuchiya et al., 1980). Cells were grown at 37oC in RPMI-1640 with 10% 
FBS, 1 x Penstrep® antibiotic (Invitrogen, Auckland, New Zealand) and 1 x 
Glutamax® (Invitrogen), and maintained at approximately 5 x 105/ml in culture. To 
count the cells, 20 μl of cell suspension was mixed with 20 μl trypan blue solution 
(250 μg/ml in PBS). Duplicate 10 μl volumes were pipetted into a haemocytometer 
and trypan blue negative cells in a given area were counted to give the number of 
viable cells per ml.  
 
2.4 Co-incubation of THP-1 cells with Map bacteria 
 
Phagocytosis was investigated by co-incubation of THP-1 cells with bacteria for 
4 h(Feola et al., 1999; Neyrolles et al., 2006; Rumsey et al., 2006). This time allowed 
measurable uptake to occur, while minimising any unwanted confounding effects 
caused by longer term exposure to compounds such as simvastatin. 
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To determine the optimum number of Map per cell, THP-1 monocytes were exposed 
to different numbers of Map. Association of fluorescent bacteria with cells was 
measured by flow cytometry. It was found that a multiplicity of infection (MOI) of 
100:1 (bacteria per cell) gave a reproducible value of approximately 25% bacterial 
association (Figure 2.10). This figure was higher than many published studies have 
used, but was most likely due to the suspended cells being less efficient in 
phagocytosing bacteria than adherent cells such as macrophages.  
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Figure 2.10. THP-1 and Map MOI. Increasing MOI of Map exposed to THP-1 cells over a 4 
h incubation period. The percentage of THP-1 cells with associated Map was measured after 
4 h incubation at 37oC (5% CO2). Values are mean +/- SEM of three independent 
experiments. 
 
 
An established method (Flaminio et al., 2002) was adapted to determine whether 
treating THP-1 cells affected association of mycobacteria. Two hundred thousand 
cells were incubated for 1 h with their respective treatments, washed once with 1x 
PBS containing 5% FBS, then incubated for 4 h with FITC-labelled Map (100:1 MOI). 
Cells were washed three times (to remove non-adherent extra-cellular bacteria) and 
resuspended in PBS/5% FBS containing 5 µg/ml propidium iodide (PI) incubated for 
5 min at room temperature, then analysed by flow cytometry (Cytomics FC 500 MPL 
flow cytometer, Beckman Coulter). PI binds to DNA by intercalating between bases 
and is generally excluded from viable cells(Haugland, 2005). Any dead cells were 
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excluded by positive PI staining, and remaining non-adherent bacteria were removed 
from analysis by size stratification (Figure 2.11).  
 
Figure 2.11. Flow cytometry of THP-1 monocytes. Live monocytes were isolated. Non-
adherent bacteria were removed by size stratification. PI positive cells were also removed. 
Particles were plotted using granularity (Y axis) and size (X axis).  
 
 
Those cells with bacteria associated were further stratified into total associated and 
intracellular. Trypan blue was added to the tubes after the initial flow cytometry run 
to quench any extra-cellular bacterial fluorescence. The suspension was run again, 
with the second result giving percentage intracellular bacteria(Wooldridge et al., 
1996).  
 
2.5 Depletion of THP-1 monocyte cholesterol levels 
 
THP-1 monocytes were depleted of cholesterol using two different drugs. Statins 
have been used effectively in a variety of studies to inhibit cellular cholesterol 
production(Gatfield and Pieters, 2000; Lioke et al., 2004). Simvastatin (Sigma) was 
used to reduce endogenous cholesterol synthesis in the cell(Almog et al., 2004; Lioke 
et al., 2004; Rise et al., 1997), while methyl-ß-cyclodextrin (MßCD) (Sigma) was 
used to actively sequester cholesterol away from the plasma membrane(Christian et 
al., 1997). These drugs were used in tandem to create a decreasing cholesterol 
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concentration gradient, with which the dependence of bacterial uptake on host cell 
cholesterol status could be measured(Gatfield and Pieters, 2000; Lamberti et al., 
2008; Lioke et al., 2004). MßCD complexed with cholesterol was used as a control to 
demonstrate there were no MßCD-related, cholesterol-independent effects. To create 
a negative gradient of cholesterol, cultured cells were incubated with 2.5 μg/ml 
simvastatin for 48 h and then resuspended at a concentration of 200,000 cells/ml 
with increasing concentrations of MßCD for 1 h.  
 
2.6 THP-1 cell proliferation following cholesterol depletion 
 
In these experiments, THP-1 cells were incubated with 2.5 μg/ml simvastatin a 
concentration well below the 4.19 μg/ml (10μM) value shown to inhibit proliferation 
by 35% over 48 h in the closely related U937 monocyte cell line (Fujino et al., 2005). 
 
MßCD-treated THP-1 cell proliferation was assessed because of evidence that this 
drug may inhibit cellular proliferation(Choi et al., 2004; Pottosin et al., 2007). Cells 
were treated with MßCD for 24 h, then permeablised (70% EtOH) to let the normally 
membrane-impermeable propidium iodide (PI) into the cells. Flow cytometry was 
used to quantitate the relative amount of DNA in each cell, allowing cell stages (G1, 
S, G2) to be categorised (Toba et al., 1992). The relative proliferation of each cell 
preparation was quantified by comparing the number of cells in S phase between 
treatments (Figure 2.12). 
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Figure 2.12. Cell cycle pattern using propidium iodide. Quantitative PI stain and 
corresponding cell cycle phase. Y axis is number of events and X axis is PI concentration. 
Note the large S phase plateau between the G0/1 and G2 phases; this is used as a measure 
of percentage proliferating cells in a suspension. Image modified from Macleod and Aldaz 
(2008). 
 
The cytometry profile for THP-1 cells was too compact to give reliable values for the 
S phase (Figure 2.13). Accordingly, the combined results of three independent 
experiments showed no significant difference in cell proliferation following MßCD-
treatment (Figure 2.14). This finding was contrary to other studies(Choi et al., 2004), 
suggesting that the technique lacked the sensitivity required to reveal any 
differences induced by MßCD.  
 
 
Figure 2.13. Cell cycle pattern using propidium iodide in THP-1 cells. Representative 
flow cytometry readout for THP-1 monocyte cells DNA content analysis. Note the lack of a 
suitable S phase “gap” (only 3.2% of cells) between the G0/G1 and G2/M phase peaks 
(arrows). The apoptotic peak is likely hidden. 
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Figure 2.14. PI cell cycle assay to measure proliferation of THP-1 cells exposed to 
MßCD. Relative proliferation of cells treated with MßCD was measured using the PI cell cycle 
method. Values are mean +/- SEM of three independent experiments. No significant 
difference was found between any of the treatments (data was analysed by a one-way 
ANOVA). 
 
 
Another measure of cell proliferation was used to test the hypothesis that 
overlapping G phases of the DNA cell cycle analysis profile obscured significant 
differences between the S phases of different treatments.  Bromodeoxyuridine 
(BrdU) is integrated into dividing cells where it replaces thymidine during DNA 
synthesis. Detected using an antibody, BrdU quantification can be used as a measure 
of relative cell proliferation. The assay was carried out using a BrdU colorimetric 
ELISA kit (Roche, Mannheim, Germany) as per the manufacturer’s instructions. The 
results showed that MßCD significantly reduced proliferation of the THP-1 cells in a 
dose dependent manner (Figure 2.15). Addition of exogenous MßCD complexed to 
cholesterol partially restored cell proliferation.   
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Figure 2.15. BrdU assay to measure proliferation of THP-1 cells exposed to MßCD. 
Effects of MCßD on proliferation of THP-1 monocytes was measured by BrdU assay. MβCD 
complexed with cholesterol was used to partially restore cholesterol. Results are expressed as 
percentage proliferation of control cells. Values are mean +/- SEM of three independent 
experiments. 10mM MßCD was significantly different from the untreated control (data 
analysed by one way ANOVA. * indicates P < 0.05).  
 
 
2.7 THP-1 cell viability  
 
To ensure that simvastatin and MßCD did not have a deleterious effect on cell 
viability, relative cell death was measured by staining cells with PI (5μg/ml for 5min). 
Flow cytometry was used to determine that at least 90% of THP-1 cells were PI 
negative (and therefore viable) at the end of each experiment.  The results of these 
experiments showed PI values for cells treated for 1 h with 10 mM MßCD were 
approximately twice that of all other treatments.  In contrast, the concentrations of 
simvastatin used throughout the following experiments did not significantly alter cell 
viability (Figure 2.16). 
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Figure 2.16. THP-1 cell death after treatment with simvastatin (SimV) and MßCD. 
The Y axis indicates the percentage of PI positive (dead) cells. No significant difference in cell 
death was found between any of the treatments and the cells only control. However, 10mM 
MßCD did show an observable, but not significant, increase in cell death. Values are mean 
+/- SEM from three independent experiments (data was analysed using a one way ANOVA). 
 
 
The observation that 10 mM MßCD had an significant effect on THP-1 cell 
proliferation (Figure 2.15), and decreased THP-1 cell viability (Figure 2.16) resulted 
in an amended regimen for the cholesterol depletion experiments.  This included 
simvastatin (2.5 µg/ml) and MßCD concentrations of 2 and 5 mM. These 
combinations had no significant effect on THP-1 cell proliferation (Figure 2.15) or 
viability (Figure 2.16). 
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2.8 Measurement of THP-1 cellular cholesterol 
 
Simvastatin and MßCD were used to create a negative cholesterol gradient to 
analyse a role for cholesterol in Map uptake by THP-1 cells. Cellular cholesterol levels 
were measured following treatment using a commercially available kit (Roche). 
Control serum was reconstituted in water to give a stock solution (2.78 g/L) that was 
further diluted to produce a standard curve (Appendix 2).  
 
To assay THP-1 cell cholesterol content, 200,000 cells were incubated with the 
treatment solution, then washed twice with PBS and resuspended in 50 μl lysis buffer 
(Appendix 3). Cells were vortexed briefly, then incubated at 37oC (shaking for 15 
min. One hundred and fifty microlitres of milliQ H2O was then added to give a final 
lysate volume of 200 μl. For analysis, duplicate 100 μl aliquots of lysate were added 
to wells of a 96 well plate, and cholesterol CHOD-PAP reagent (100 μl) added to 
each. The plate was incubated at 37oC (shaking) for 15 minutes to allow colour 
development, then read on a spectrophotometer (Spectromax 190) at 490 nm. 
Cholesterol content was expressed as micrograms of cholesterol per milligram of 
cellular protein, measured used an established method(Sandermann and Strominger, 
1972), detailed in Appendix 4. A negative gradient of cholesterol was created, 
although the values were not significantly different (Figure 2.17). 
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Figure 2.17. Cholesterol depletion of THP-1 monocytes. THP-1 cells were treated with 
simvastatin (SimV) and methyl-β-cyclodextrin (MßCD) to create a negative cholesterol 
gradient. Cellular cholesterol levels were measured using an ELISA kit (Roche). Results are 
expressed as μg of cholesterol/mg of cellular protein. Values are means +/- SEM from three 
independent experiments. While a negative cholesterol gradient was created, no significant 
differences were found between any of the treatments (data was analysed using a one-way 
ANOVA).  
 
 
2.9 Visualisation of cellular cholesterol by filipin fluorescence 
 
Fluorescence microscopy was also used to visualise differences in the cholesterol 
content of treated and control cells (Figure 2.18). Filipin is a polyene antibiotic that 
binds cholesterol in mammalian cells(Drabikowski et al., 1973; Gatfield and Pieters, 
2000). Treated cells were incubated with 0.05% filipin (30 min) at 37oC, then 
visualised using fluorescence microscopy with excitation (360 nm) and emission (405 
nm) through a standard UV filter block. Filipin fluorescence decreased with 
simvastatin and MßCD-mediated cholesterol depletion (Figure 2.18). 
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Figure 2.18. Cholesterol content of THP-1 cells. Filipin staining (blue) of cellular 
cholesterol in untreated THP-1 cells (top) and following treatment with 2.5 μg/ml simvastatin  
(middle) and 2.5 μg/ml simvastatin with 5 mM MßCD (bottom). Corresponding images (left) 
are of the same cells using differential interference contrast (DIC). Scale bar indicates 20 μm. 
 
 
2.10 Flow Cytometry 
 
For flow cytometry, cells were prepared as above (Section 2.4) and analysed on a 
Cytomics FC 500 MPL flow cytometer (Beckman Coulter). FITC and PI were detected 
in FL1 and FL2 channels respectively (green and red fluorescence). Preliminary 
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samples were used to adjust compensation settings (to ensure no cross-wavelength 
contamination) and optimise the protocol. 
 
2.11 Microscopy 
 
Fluorescent imaging was carried out on an Axio-imager Z1 upright microscope with a 
40x EC plan neofluar lens (1.3 numerical aperture) (Zeiss, Oberkochen, Germany). 
An axiocam MRm camera was used to capture images with axiovision software. 
Immersion oil was Immersol 518 F (Zeiss).  
 
A generic method for immunofluorescence microscopy was derived from several 
studies(Kelley and Schorey, 2003; Rumsey et al., 2006). Cells infected with bacteria 
were cytospun onto coverslips (500 rpm, 5 min), then fixed with 4% formaldehyde 
for 30 min. The cells were permeablised with PBS containing 0.1% Triton X-100 (10 
min) and formaldehyde-induced auto-fluorescence quenched with PBS containing 
1.5 mg/ml glycine. The cells were washed once more with PBS/2.5% FBS, then 
blocked for 1 hour at 37oC (PBS/5% FBS) before being exposed to primary antibody 
(raised in rabbit, specific antibody details given in relevant sections) diluted 1:250 in 
PBS/2.5% FBS overnight at 4oC. After washing twice more with PBS/0.1% Triton X-
100 and once with PBS-2.5% FBS, cells were incubated with chicken anti-rabbit 
secondary antibody (conjugated to the red fluorophore Texas-red) diluted 1:1000 in 
PBS-2.5% FBS for 4 h at room temperature. A final two washes (PBS/0.1% Triton X-
100) were carried out, then cell nuclei were were stained with PBS/2.5% FBS 
containing Hoechst (0.25 μg/ml) for 5 minutes at 37oC. Coverslips were blotted dry 
and mounted onto slides with 10 μl Phenylenediamine to reduce fading and imaged. 
In addition to fluorescent images, differential interference contrast images  
 
By taking slices through the cell, bacteria could be localised within cells in 3 
dimensions. The fluorescent images generated from these experiments are 
presented in three parts. The central image (A) is in two dimensions, through the X 
and Y planes. The outer rectangular images (B, C) show sections through the Z axis, 
thus allowing discrimination between extra- and intra-cellular bacteria (Figure 2.19).  
 
 
 33
 
Figure 2.19. Layout of pictures. Schematic of image presentation. The central image (A) 
shows cells in 2D (X and Y axes), while the outer boxes (B, C) show slices through the cell (Z 
axis),  
 
2.12 Chemical generation of spheroplasts forms of Map 
 
Spheroplasts of Map strain Dominic were generated using the method of Hines and 
Styer (2003). Briefly, 1 million bacillary Map were suspended in 1 ml of Middlebrook 
7H9 media containing 1% glycine for 96 h at 37oC (shaking) before being 
resuspended in a 1 ml solution containing 7H9 broth, 0.5 M sucrose, 20 mM MgCl2, 
1% glycine and 30 μg/ml lysozyme. Bacteria were then incubated for a further 10 
days in this solution. Untreated control bacteria were maintained for 14 days in 7H9 
media.  
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Chapter 3. Trafficking of Map through 
THP-1 monocytes 
 
3.1 Introduction 
 
Mycobacteria are masters of intracellular persistence. They have adapted many tools 
to survive the hostile environment inside phagocytes, even when faced with a 
competent immune response(Britton et al., 1994). These adaptations make 
mycobacteria extremely successful pathogens of animals and humans. 
 
3.1.1 The phagocytic pathway 
 
The phagocytic pathway is split into three phases, based on the phagosome’s 
sequential interaction with endocytic organelles. Typically, a bacterium is taken up by 
the cell and immediately deposited into a phagosome, which fuses with early 
endosomes, then late endosomes, and finally lysosomes. Bacteria are destroyed by 
the acidic pH and hydrolytic enzymes present in the mature phagolysosome(Beron et 
al., 2002; Desjardins et al., 1994a; Desjardins et al., 1994b).  
 
Early and late phagosomal compartments are differentiated by their Rab protein 
composition. These small GTP-binding proteins of the Rab subfamily are a series of 
molecular switches that control membrane traffic in eukaryotic cells. They oscillate 
between an inactive, soluble, GDP-bound form and an active, membrane-bound 
form(Bruckert et al., 2000). Rab 5a and Rab 7 are associated with the endocytic 
pathway of almost every cell type(Bruckert et al., 2000). 
 
The active form of Rab 5a is acquired immediately after phagocytosis and formation 
of the phagosome. It works with a phosphatidylinositol 3-kinase (PI 3-kinase) to 
recruit early endosomal antigen 1 (EEA1) to early phagosomes. This results in the 
docking and fusion of further early endosomal machinery, and facilitates maturation 
from an early to a late phagosome(Kurosu and Katada, 2001; Vieira et al., 2002).  
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Rab 7 is a marker of late phagosomes. It is recruited to the phagosomal membrane 
where it interacts with RILP (Rab 7-interacting lysosomal protein) which then bridges 
phagosomes with dynein-dynactin, a motor protein associated with 
microtubules(Harrison et al., 2003). This complex mediates transport of the 
phagosome along microtubules towards the microtubule organising centre, and 
facilitates the construction of tubular extensions which facilitate fusion of the 
phagosome with late endosomes and lysosomes. Although the processes governing 
the functioning of late endosomal/phagosomal molecules are incompletely 
understood, markers such as Rab 7 are thought to facilitate the hybridisation of late 
phagosomal components with lysosomes. This generates the mature acidic/hydrolytic 
phagolysosomal compartment(Harrison et al., 2003; Vieira et al., 2002).  
 
3.1.2 Mycobacterial manipulation of the phagocytic pathway 
 
After being phagocytosed, pathogenic mycobacteria interrupt phagosome trafficking 
and persist in compartments that are much less acidic than normal(Anes et al., 2006; 
Hart et al., 1987; Malik et al., 2000). Several mechanisms are thought to contribute 
to a reduction in acidity in the mycobacterial phagosomal compartments. Some 
mycobacterial pathogens arrest phagosome maturation, and persist inside an early 
endosomal compartment. Disruption of proteins facilitating the transition from early 
to late endosomal compartments has been implicated in M. tuberculosis and M. bovis 
infection models(Clemens et al., 2000a; Clemens et al., 2000b; Sun et al., 2007). 
Despite acquisition of the lysosomal marker Lamp-1, phagosomes containing M. 
avium actively inhibit fusion of vacuoles containing cellular ATPase with its 
phagosomal membrane. This impairs acidification of the mature M. avium containing 
compartment(Sturgill-Koszycki et al., 1994). While growth of most mycobacteria 
including M. tuberculosis is halted by exposure to a mature phagolysosome, 
M. avium is still able to replicate even in this harsh environment. This suggests 
different susceptibility to the toxic phagosomal environment between species, 
despite similar strategies to prevent phagosome-lysosome fusion(Gomes et al., 
1999).  
 
TACO (tryptophan aspartate-containing coat protein), also known as coronin 1a 
(hereafter referred to as TACO), transiently associates with late endosomes under 
normal conditions. However there is evidence that TACO is retained on the 
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phagosomes of some pathogenic bacteria and mycobacteria for extended 
periods(Ferrari et al., 1999; Schuller et al., 2001; Zheng and Jones, 2003). This 
extended association is thought to contribute to the attenuated fusion of 
phagosomes with lysosomes by interfering with the recruitment of lysosome delivery 
machinery to the phagosome. Interestingly, the resident macrophages of the liver 
(termed Kupffer cells) lack the TACO protein and are able to rapidly process 
mycobacteria-containing phagosomes and facilitate fusion with lysosomal 
organelles(Ferrari et al., 1999). 
 
3.1.3 Trafficking of Map through cells 
 
Map inhibit phagosome maturation in murine and bovine cells. They persist and 
replicate in sub-epithelial macrophages in the face of a robust immune response 
from the host(Chacon et al., 2004; Hostetter et al., 2005; Woo et al., 2007). Despite 
comprehensive debate about the role of Map in human disease, there is a paucity of 
data concerning the fate of Map in human phagocytes(Rumsey et al., 2006).   
 
This chapter examines the uptake and trafficking of Map by human THP-1 cells, asks 
whether live bacteria can arrest the phagocytic pathway and, if so, seeks to identify 
the compartments to which these bacteria traffic. This was investigated by 
determining whether intracellular compartments containing live Map exhibited 
reduced acidity compared with those containing dead bacteria. Map-containing 
compartments were also examined using antibodies to early (Rab 5a) and late (Rab 
7) endosomal markers, and to the TACO protein.  
 
3.2 Results 
 
3.2.1 Acidity of Map-containing phagosomes 
 
Phagosomes containing pathogenic mycobacteria are recalcitrant to fusion with 
lysosomes, and are less acidic than compartments that contain inactivated 
bacteria(Clemens and Horwitz, 1995; Woo et al., 2007). The following experiments 
were designed to investigate whether Map bacteria traffic to acidic phagolysosomes 
(the product of lysosomal fusion with a phagosome) over 48 h. To establish whether 
a cell wall constituent was responsible for impaired co-localisation, or whether the 
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inhibition of fusion is an active process, comparisons were made between live 
mycobacteria and cells killed with either heat or with formaldehyde which conserves 
the majority of the antigenicity of whole bacterial cells(Cryz et al., 1982). The acidity 
of bacteria-containing compartments was analysed first using neutral red, and 
confirmed using lysotracker red. 
 
Percentage intracellular bacterial co-localisation with acidic areas of the cell, marked 
by neutral red fluorescence (Figure 3.1), was compared between live Map and 
formaldehyde- (4% for 1 h) and heat-killed (85oC for 15 min) controls. 50:1 FITC- 
labelled bacteria were incubated with 2500K/ml cells in antibiotic free media. After 4 
h incubation, the cells were washed three times with media to remove extracellular 
bacteria, then incubated for the remaining 44 h. Neutral red (final concentration 
5μg/ml) was added for the final 2 h of incubation (Ghigo et al., 2002). Bacteria were 
revealed by direct immunofluorescence of FITC, and neutral red was observed using 
excitation and emission filters for Texas Red. The Z stack function (p32 section 2.11) 
was used to obtain a 3 dimensional view of the cells, allowing exclusion of 
extracellular bacteria from enumeration. The number of bacteria co-localising with 
neutral red positive compartments was enumerated by counting 50 
bacteria/preparation. Significantly fewer live Map were found in acidic compartments 
at 48 h when compared with heat- and formaldehyde-treated Map (Figure 3.2).  
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Figure 3.1. Map and acidic compartments. Map co-localised with neutral red stained 
acidic compartments inside THP-1 monocytes. The Z-stack function (top and right bars) 
confirmed that bacteria were intra-cellular. Images show acidic (white arrow) and non acidic 
(grey arrow) compartments inside the cell (A), containing FITC-labelled Map (B). A DIC image 
(C) fluorescent merged image (D) are also shown. Images represent three independent 
experiments. Scale bar indicates 20 μm. 
 
A B 
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Figure 3.2. Co-localisation of Map bacteria with neutral red staining. Values are 
mean +/- SEM from three independent experiments. Live Map co-localised with significantly 
fewer neutral red positive vacuoles than formaldehyde or heat-killed Map (* = P<0.001, data 
was analysed using a one way ANOVA).   
 
A more robust technique was used to confirm and expand on these findings.  
Lysotracker red is a fluorescent dye that migrates to acidic organelles. It is widely 
used in the literature to label lysosomes(Via et al., 1997; Zheng and Jones, 2003). 
Bacteria were incubated with cells as in the neutral red experiments (p 37, section 
3.2.1). Lysotracker red (final concentration 500nM) was added to the media for the 
final 2 h of incubation. Cells were fixed with 4 % formaldehyde and visualised using 
fluorescence microscopy. Phagosomes were classed as strongly staining, weakly 
staining or not stained, all counts were verified by an independent observer. 
 
Lysotracker red confirmed that live Map and M. bovis reside in compartments with 
reduced acidity compared with formaldehyde (Figure 3.3) and heat-treated Map (not 
shown). Live Map, as well as M. bovis, co-localised significantly less with strongly 
staining/acidic areas of the cell compared with formaldehyde- and heat-killed Map 
(Figure 3.4). 
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Figure 3.3 Bacteria and lysotracker. Bacteria and lysotracker-labelled acidic 
compartments at 2 h post infection. Lysotracker channel images were taken at the same 
exposure. Rows are (from top) nuclei (blue) and DIC images merged, bacteria (green), 
Lysotracker (red), and a nuclei, bacteria and lysotracker merged image. Columns are (from 
left) cells without bacteria, live Map, formaldehyde-killed Map, live M. bovis. Arrows indicate 
no acidity (white), weakly acidic (yellow) and strongly acidic compartments (orange). Images 
represent three independent experiments.  Scale bar indicates 20 μm. 
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Figure 3.4 Bacterial co-localisation with lysotracker. Proportion of bacteria co-
localising with lysotracker-labelled acidic compartments at 2 (top) and 48 h (bottom) post 
infection. Bacterial phagosomes were visualised by microscopy, and classed as strongly 
stained, weakly stained or not stained. Values are mean +/- SEM from three independent 
experiments. At 2 and 48 h, live Map and M. bovis co-localised significantly less with strongly 
staining acidic compartments compared with heat-killed Map. (**, P < 0.01; *, P < 0.05; 
data was analysed by one way ANOVA).  
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To further examine the acidity of Map-containing compartments, images were 
quantified with ImageJ software (MBF (McMaster Biophotonics Facility), National 
institute of Health, Bethesda, MD, USA). After subtraction of background, the 
fluorescence intensity for each bacterial type (live Map, M. bovis, formaldehyde-killed 
Map and heat-killed Map) was calculated for 10 fields containing at least 20 bacteria 
each. Fluorescence intensity data was averaged and compared (Figure 3.5).  
 
These experiments showed that at 2 h post infection, live Map and M. bovis resided 
in compartments with reduced acidity compared with formaldehyde-treated Map. 
Unexpectedly, heat killed Map compartments also showed reduced acidity compared 
with formaldehyde-killed Map. This difference was significant. This could be due to 
membrane compromised bacteria ‘leaking’ cytoplasmic contents into the lumen of the 
phagosome, resulting in a temporary decrease in acidity. At 48 h, no difference was 
seen between heat- and formaldehyde-killed Map, or interestingly, M. bovis 
containing phagosomes. However Map containing compartments showed reduced 
acidity. This difference was not significant. Why M. bovis compartments did not show 
reduced acidity compared with killed bacteria at 48 h is still unclear. This data 
supports the neutral red and lysotracker results for live Map, and further suggests 
that a component secreted from bacteria may affect phagosomal acidity.  
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Figure 3.5. Lysotracker fluorescence intensity of bacterial phagosomes. Lysotracker 
fluorescence of bacterial phagosomes at 2 (top) and 48 h (bottom) post infection. Ten 
separate fields (each containing at least 20 bacterial phagosomes) were analysed per 
bacterium. Average lysotracker fluorescence was calculated using ImageJ software. At 2 h, 
heat-killed and live Map containing compartments showed significantly reduced acidity 
compared with formaldehyde-killed Map containing compartments. M. bovis intensity was 
also reduced, although this difference was not significant. At 48 h, the intensity of Live Map 
phagosomes was observably lower compared with heat and formaldehyde-killed bacteria, and 
also M. bovis. However this difference was not significant. Values are mean +/- SEM (* = P < 
0.05, data was analysed by one way ANOVA). 
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3.2.2 Using endosomal markers to characterise Map-containing 
phagosomes 
 
Antibodies against Rab 5a (found on early endosomal compartments) and Rab 7 
(found on late endosomal compartments) were used to label Map-containing 
phagosomes, to determine bacterial progression through the phagocytic pathway. 
Bacteria (MOI 50:1) were pulsed for 1 h and chased for 2 h, or pulsed for 4 h and 
chased for 48 h as described previously (p. 33, section 2.11). Briefly, the cells were 
then mounted on coverslips, fixed, and stained with anti-Rab 5a antibody (Santa-
Cruz Biotechnology, Heidelberg, Germany), diluted 1:250. After washing, bound 
antibody was detected with a secondary antibody conjugated to Texas-red, diluted 
1:1000. Live and formaldehyde-killed Map were compared with live M. bovis, as well 
as heat-killed E. coli BL21. 
 
There was no evidence of mycobacterial co-localisation with Rab 5a at either time 
point (Figure 3.6). Diffuse staining of what appeared to be small vacuoles was seen, 
but no punctate Rab 5a, as reported elsewhere in M. avium infected 
macrophages(Kelley and Schorey, 2003). Few intact heat-killed E. coli were 
visualised inside the cells at 48 h, indicating that trafficking and destruction were 
most likely complete by this time (Root et al., 1972). 
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Figure 3.6. Bacteria and Rab 5a. Representative images of bacteria and the early 
endosomal marker Rab 5a inside THP-1 monocytes at 2 h post infection. Rab 5a did not co-
localise with any of the bacteria investigated, at any time point. Columns are (from left) live 
Map, formaldehyde-killed Map, M. bovis, heat killed E. coli BL21. Rows are (from top) nuclei 
(blue) and DIC images merged, bacteria (green), Rab 5a (red), and nuclei, bacteria and Rab 
5a merged image. Images represent three independent experiments. Scale bar indicates 
20 μm.  
 
 
To investigate whether the failure to visualise bacteria in Rab 5a-containing 
compartments was related to Rab 5a disappearance from the THP-1 cell phagosomes 
by the 2 h time point or simply an inability to visualise Rab 5a, heat-killed E. coli 
containing phagosomes were analysed immediately after phagocytosis, when Rab 5a 
recruitment and activity is reportedly maximal (Kitano et al., 2008). THP-1 cells were 
exposed to heat-killed E. coli (MOI 50:1) for 15 mins only before being washed, 
fixed, stained and imaged as described above (p43, section 3.2.2). However, no Rab 
5a co-localisation with heat-killed E. coli was observed. Different concentrations of 
primary anti-Rab 5a antibody (1:200, 1:100) were used in an attempt to increase 
sensitivity, with no success. 
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Bacterial co-localisation with Rab 7 was visualised using an anti-Rab 7 antibody 
(Santa-Cruz Biotechnology) and the same labelling conditions as for Rab 5a. Rates of 
Rab 7 co-localisation were compared to pathogenic M. bovis, as well as heat-killed 
E. coli BL21.  
 
These experiments indicated that the majority of live Map-containing phagosomes 
had acquired Rab 7 by 2 h post infection. This was not significantly different from M. 
bovis, formaldehyde- or heat-killed Map or E. coli strain BL21. At 48 h, the majority 
of M. bovis, live Map and formaldehyde killed-Map resided in Rab 7 positive 
compartments (Figure 3.8, 3.7). In contrast, few heat-killed E. coli were visualised at 
48 h post infection. 
 
 
 
Figure 3.7. Bacteria and Rab 7. Representative image of Map bacteria co-localising with 
the late endosomal marker Rab 7 inside THP-1 monocytes at 2 h post infection. Columns are 
(from left) live Map, formaldehyde-killed Map, M. bovis, heat killed E. coli BL21. Rows are 
(from top) nuclei (blue) and DIC images merged, bacteria (green), Rab 7 (red), and nuclei, 
bacteria and Rab 7 merged image. Images represent three independent experiments. Scale 
bar indicates 20 μm. 
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Figure 3.8. Co-localisation of bacteria with Rab 7. These graphs indicate bacterial 
containing phagosomes exhibit co-localisation with Rab 7 at 2 h (top) and 48 h (bottom) post 
infection. Values are mean +/- SEM from three independent experiments. No significant 
difference was found between bacteria at either time. (Data was analysed using a one-way 
ANOVA).  
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3.2.3 TACO (Coronin-1a) 
 
To examine whether Map bacteria co-localised with the TACO protein at 2 and 48 h, 
cells were prepared and exposed to bacteria as for Rab 5a, then stained with anti-
TACO antibody raised in rabbit (Bethyl Laboratories, Murarrie, Queensland, Australia) 
diluted 1:250. Cells were washed, then bound antibody was probed using a 
secondary antibody conjugated with a red fluorophore as described above (p43, 
section 3.2.2). These experiments showed little TACO localisation with bacterial 
phagosomes at 2 h post infection. However, at 48 h post infection, approximately 
40% of both M. bovis and Map containing compartments showed evidence of TACO. 
No association was seen with phagosomes containing heat killed E. coli BL21 at 2 h 
(Figure 3.9, 3.10). 
 
 
 
Figure 3.9. Bacteria and the TACO protein. Representative picture of bacteria and TACO 
inside THP-1 monocytes at 48 h post infection. Columns are (from left) live Map, 
formaldehyde-killed Map, M. bovis, heat killed E. coli BL21. Rows are (from top) nuclei (blue) 
and DIC images merged, bacteria (green), TACO (red), and a nuclei, bacteria and TACO 
merged image. Images represent three independent experiments. Scale bar indicates 20 μm. 
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Figure 3.10. Co-localisation of bacteria with TACO.  These graphs indicate bacterial 
containing phagosomes exhibiting co-localisation with TACO at 2 h (top) and 48 h (bottom) 
post infection. Values are mean +/- SEM from three independent experiments. No TACO 
staining was seen at 2 h. No significant difference was found between other bacteria at either 
time. (Data was analysed using a one way ANOVA) 
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3.3 Discussion 
 
Despite the isolation of Map in tissue and blood from CD patients (Abubakar et al., 
2008), there have to date been few studies of Map trafficking and persistence in 
human derived cells. Results presented in this chapter show that live Map 
phagocytosed by THP-1 human monocytes reside in compartments that exhibit 
reduced acidity when compared with compartments containing formaldehyde- or 
heat-killed bacteria. This observation suggests the presence of cell wall antigens 
alone is insufficient to interrupt phagosome trafficking and that Map disruption of 
acidification of the phagosome is most likely an active process. The observation that 
heat-killed (and membrane compromised) Map show reduced lysotracker intensity at 
2 h post infection indicates this may be due to a secreted component. 
 
Manipulation of the phagocytic pathway and persistence in compartments 
recalcitrant to fusion with lysosomes is well characterised in M. tuberculosis, 
M. leprae and M. bovis infection of human cells(Anes et al., 2006; Hart et al., 1987; 
Sun et al., 2007). There is also evidence of altered trafficking of live Map in 
peripheral polymorphonuclear cells (PMNCs) isolated from patients with CD, 
ulcerative colitis (an inflammatory bowel condition similar to CD) and healthy 
individuals(Rumsey et al., 2006). The observation that Map survival in PMNCs from 
CD and healthy patients is comparable to that of M. tuberculosis(Rumsey et al., 
2006). Collectively, these findings support the results presented here, which suggest 
that live Map has the ability to manipulate the phagocytic pathway in human 
phagocytic cells in the same way as it does in murine and bovine infection(Woo et 
al., 2007).   
 
In this study, the use of 3Dimensional microscopy proved to be invaluable in 
distinguishing extra-cellular bacteria from those inside cells. Normally, antibiotic 
protection assays are used, where extra-cellular bacteria are killed before 
enumeration of intra-cellular bacteria (by plate counts) following cell lysis. However, 
this technique was not ideal as, like all mycobacteria, Map are extremely slow 
growing. By staining the plasma membrane and using 3D microscopy, intra-cellular 
bacteria could be clearly identified and counted. Furthermore, compared to 
conventional microscopy, 3D microscopy reduces the chance of false positives as a 
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result of bacteria being cytospun (technique to spin non-adherent cells onto a 
coverslip surface for staining and viewing under a microscope) onto the cell surface.  
 
The failure to detect Rab 5a co-localisation with bacterial phagosomes at any time 
point was unexpected, given the punctate staining around bacterial phagosomes 
described by Kelley and Schorey (2003). The diffuse staining that was observed 
suggested a number of possibilities. Expression levels of Rab 5a in THP-1 monocytes 
may be too low for accurate visualisation using this technique. Other possibilities are 
that the antibody was impaired and unable to bind to Rab 5a, or that the majority of 
Rab 5a was already removed from the phagosomal membrane at the time of 
staining. However, E. coli treated THP-1 cells stained immediately after phagocytosis 
(15 min) showed no evidence of bacterial co-localisation as reported elsewhere 
(Perskvist et al., 2002). M. avium reportedly resides in a Rab 5a-containing 
compartment (Kelley and Schorey, 2003), and was analysed as an additional control. 
However, no Rab 5a staining was seen. Collectively, these results suggest that the 
immuno-labeling technique used here lacked the sensitivity to detect of Rab 5a in 
THP-1 cells. There is not enough evidence to class the lack of Rab 5a on phagosomal 
membranes as a true negative. 
 
In marked contrast to Rab 5a, Rab 7 co-localisation was seen with live, 
formaldehyde- and heat-killed Map in THP-1 monocytes. Likewise, live M. bovis were 
also observed in compartments which stained strongly for Rab 7 at 48 h post 
infection. Rab 7 is a crucial molecule for the survival of mycobacteria in host cells; 
both M. tuberculosis and M. bovis-containing phagosomes display strong Rab 7 
staining(Clemens et al., 2000b; Sun et al., 2007). In macrophages, live M. bovis 
secretes a protein that inactivates Rab 7, rendering it unable to interact with the Rab 
7-interacting lysosomal protein (RILP). As a result, the inactive, GDP-bound form of 
Rab 7 predominates in cells infected with live M. bovis whereas, conversely, the 
majority of Rab 7 in cells containing killed M. bovis is in the active GTP-bound form. 
Intriguingly, live Salmonella typhimurium also secretes a factor that interferes with 
Rab 7 signalling via impaired association with RILP, leading to significantly reduced 
lysosomal fusion(Catron et al., 2004). The failure of M. bovis containing phagosomes 
to acquire RILP arrests phagosome trafficking and impairs fusion with lysosomes(Sun 
et al., 2007). This suggests that Rab 7 is a key player in the manipulation of cells by 
M. bovis and S. typhimurium. The antibody mediated visualisation used in these 
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assays does not allow the characterisation of Rab 7 into the active/inactive form. 
However, given the attenuated acidification of live Map phagosomes in THP-1 
monocytes, live Map bacteria may use a similar system to reduce acidification of their 
phagosomes. A role for Rab 7 inactivation in Map infection is currently under 
investigation by the helicobacter research lab. 
 
The role of the TACO protein in the persistence of some pathogenic mycobacteria 
has been shown in several studies(Gatfield and Pieters, 2000; Kaul, 2008; Kaul et al., 
2004). However, to date, the association of Map bacteria with the TACO protein has 
not been investigated. In this study, Map (live and formaldehyde-killed)-containing 
phagosomes showed evidence of TACO staining at 48 h post infection. M. bovis-
treated cells displayed similar staining. It is unclear whether this association is 
specific to these mycobacteria in THP-1 monocytes as the majority of heat-killed 
E. coli had been processed at this time point. However the involvement of the TACO 
protein with related mycobacteria makes this likely.    
 
Chemically-mediated down-regulation of the TACO gene transcription in THP-1 
monocyte-derived macrophages significantly reduces both the uptake and survival of 
M. tuberculosis (Anand and Kaul, 2005) whereas live M. bovis actively retains the 
TACO protein on its phagosomal membrane by secreting a coronin-interacting 
protein (CIP). This protein is also expressed by M. tuberculosis, but not the non-
pathogenic M. smegmatis(Deghmane et al., 2007). When the interaction between 
CIP and TACO is reduced (after treatment with interferon gamma), increased 
phagolysosome fusion of BCG-containing compartments is observed(Deghmane et 
al., 2007). In the present study, phagosomes containing formaldehyde-killed Map 
phagosomes also exhibited TACO protein staining, suggesting that cell wall 
constituents may play a role in the retention of TACO in THP-1 cells.  
 
The role of TACO is currently a subject of debate in the literature(Schuller et al., 
2001), with some contending that TACO is a crucial mediator of intracellular 
mycobacterial survival(Jayachandran et al., 2008; Jayachandran et al., 2007; Kaul, 
2008). TACO typically associates only transiently with the maturing phagosome.  
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However, in mycobacterial infection, it can remain associated with the phagosome in 
a cholesterol-dependent manner, leading to reduced fusion of the compartment with 
lysosomes(Deghmane et al., 2007). In light of this and other recent studies that 
reveal a role for cholesterol in the inactivation of Rab 7 in other cell 
systems(Deghmane et al., 2007; Huynh et al., 2008), further experiments were 
designed to explore the role of cholesterol in Map infection (Chapter 4).  
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Chapter 4. Cholesterol involvement in 
Map uptake and fate 
 
4.1 Introduction 
 
Cholesterol is ubiquitous in the mammalian cell; it is found in the plasma membrane 
and intracellular membranes, which are enriched to varying degrees (Soccio and 
Breslow, 2004). Cholesterol is an essential constituent of these membranes, affecting 
a wide variety of processes such as receptor-mediated signalling, ion flow and 
enzymatic activity (Gimpl et al., 1997).  
 
Cholesterol has been implicated in the uptake of several pathogenic bacteria and 
mycobacteria into host cells. Moreover, uptake via cholesterol-dependent pathways, 
and recruitment of excess cholesterol to the phagosomal membrane, is hypothesised 
to enhance survival and persistence of some bacterial (B. pertussis and S. enterica) 
and mycobacterial pathogens (M. avium, M. tuberculosis, M. bovis) inside the cell 
(Gatfield and Pieters, 2000; Goluszko and Nowicki, 2005; Peyron et al., 2000; 
Rosenberger et al., 2000). In contrast, depletion of cellular cholesterol results in 
decreased viability for bacteria such as Salmonella typhimurium and M. tuberculosis 
(Catron et al., 2004; Lamberti et al., 2008; Pandey and Sassetti, 2008).   
 
Bacteria taken up in this way persist in compartments recalcitrant to fusion with 
lysosomes. One hypothesis is that by entering at cholesterol-rich areas of the cell, 
microbes are transferred directly into the endocytic rather than phagocytic pathway 
of cells (Naroeni and Porte, 2002; Rodriguez et al., 2001).  The TACO protein 
interacts only briefly with late endosomes under normal conditions but it is retained 
on the phagosomes of some pathogenic bacteria and mycobacteria for extended 
periods (Ferrari et al., 1999; Zheng and Jones, 2003). This extended association is 
thought to contribute to the attenuated fusion of phagosomes with lysosomes by 
interfering with the recruitment of lysosome delivery machinery to the phagosome. 
In M. bovis-infected cells, retention of the TACO protein on phagosomes depends on 
cholesterol (Gatfield and Pieters, 2000). In addition, a recent study demonstrated 
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that cholesterol-rich compartments inside the cell are intrinsically less likely to fuse 
with lysosomes (Huynh et al., 2008). 
 
Despite involvement in several bacteria and mycobacterial infections, the role of 
cholesterol in Map infection has yet to be elucidated. The aim of this chapter was to 
determine whether the uptake and persistence of Map bacteria in THP-1 monocytic 
cells is mediated by cholesterol. The role of cholesterol in uptake of Map was 
investigated using depletion and co-localisation techniques while the association of 
Map with membrane-bound cellular cholesterol was explored using microscopy. In 
addition, the effect of cholesterol depletion on Map persistence was analysed by 
enumeration of viable bacteria following long term co-culture.  
 
4.2 Results 
 
4.2.1 Map uptake by THP-1 monocytes and cholesterol  
 
Flow cytometry was used to quantify the association and uptake of FITC-labelled 
bacteria into THP-1 cells. First, a decreasing gradient of cholesterol in the cells was 
created by pre-treatment with simvastatin (2.5 μg/ml) and MβCD (2 and 5 mM) for 
48 and 1 h, respectively (p23, section 2.5). Bacteria were added and the combined 
culture of bacteria, cells, simvastatin and MβCD were incubated for 4 h at 37oC (5% 
CO2) The cells were then centrifuged (1400 rpm for 5 min) to remove media and 
non-adherent bacteria, before being resuspended in 1 ml of PBS containing 5% FBS 
and 5 μg/ml PI, then analysed by flow cytometry (p 21, section 2.4). Each sample 
was run twice, with trypan blue (final concentration 0.25%) added between runs to 
quench extra-cellular bacterial fluorescence (Wooldridge et al., 1996). This gave 
values for total associated, as well as internalised bacteria. Non-adherent bacteria 
and dead cells (PI positive) were removed from analysis using size segregation and 
isolation (gating) of the live monocyte smear, respectively (Figure 2.9). 
 
Two species of bacteria were used as controls to prove this approach could 
accurately visualise differences between cholesterol-dependent and independent 
uptake. M. bovis, a mycobacterial relative of Map, enters macrophage cells via a 
cholesterol-dependent pathway (Gatfield and Pieters, 2000) and was used as a 
positive control whereas E. coli strain BL21, which is internalised into macrophages 
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via a cholesterol-independent mechanism (Gatfield and Pieters, 2000), provided a 
negative control. 
 
The control experiments showed that both the association and internalisation of 
FITC-labelled M. bovis decreased with decreasing cellular cholesterol over a 4 h 
period. This decrease was significant at the lowest concentration of cholesterol 
(Figure 4.1). In contrast, E. coli uptake was not significantly affected by lowered 
cholesterol. However, total association of E. coli was significantly decreased in the 
MβCD treatments (2 and 5 mM). This was most likely due to general anti-adherence 
effects, resulting from the removal of cholesterol from the plasma membrane (Figure 
4.2).   
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Figure 4.1. Association and internalisation of M. bovis into THP-1 monocytes over 
4 h along a negative cholesterol gradient. Results show bacteria associated/internalised 
for each treatment as a percentage of control treatment. Values are mean +/- SEM of three 
independent experiments. (Data was analysed by one way ANOVA. * indicates P < 0.05). 
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Figure 4.2. Association and internalisation of E. coli into THP-1 monocytes over 4 h 
along a negative cholesterol gradient. Results show bacteria associated/internalised for 
each treatment as a percentage of control treatment. Values are mean +/- SEM of three 
independent experiments. (Data was analysed by one way ANOVA. * indicates P < 0.05). 
 
 
While decreasing cellular cholesterol caused little or no changes in the association 
and internalisation of E. coli, the uptake of living Map into THP-1 monocytes was 
significantly reduced by cholesterol depletion with simvastatin and MβCD (Figure 
4.3). Moreover, re-addition of cholesterol restored Map uptake and association. 
Similar results were obtained with formaldehyde-killed Map, with cholesterol 
depletion again causing decreased association and uptake (Figure 4.4). Thus, Map 
are taken up into THP-1 monocytes via a cholesterol-dependent mechanism.  
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Figure 4.3. Association and internalisation of live FITC-labelled Map into THP-1 
monocytes over 4 h along a negative cholesterol gradient. Results show bacteria 
associated/internalised for each treatment as a percentage of control treatment. Values are 
mean +/- SEM of three independent experiments. (Data was analysed by one way ANOVA. * 
indicates P < 0.05). 
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Figure 4.4. Association and internalisation of formaldehyde-killed, FITC-labelled 
Map into THP-1 monocytes over 4 h along a negative cholesterol gradient. Results 
show bacteria associated/internalised for each treatment as a percentage of control 
treatment. Values are mean +/- SEM of three independent experiments. (Data was analysed 
by one way ANOVA. * indicates P < 0.05). 
 
 
Fluorescence microscopy was used to extend these observations. FITC-labelled 
bacteria were incubated for 4 h with THP-1 cells, which were then fixed. Cell 
membrane cholesterol was labelled with the fluorophore filipin, as described 
previously (p 30, section 2.9). Additionally, the actin cytoskeleton of the cells was 
labelled with Texas-red phalloidin (Molecular Probes, Invitrogen). This fluorescently-
tagged actin-binding peptide allowed visualisation of actin polymerisation associated 
with the entry of bacteria into cells. In these experiments, it was used as a marker of 
bacterial internalisation (Ibrahim-Granet et al., 2003).  
 
These experiments showed cholesterol aggregation at the site of the majority of M. 
bovis entering THP-1 (Figure 4.5).  In contrast, although actin polymerisation was 
observed, there was little evidence for cholesterol aggregation at the site of E. coli 
entry (Figure 4.6). 
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Figure 4.5. Cholesterol aggregation at the site of internalisation of live FITC-
labelled M. bovis into a THP-1 monocyte. FITC-labelled mycobacteria (green, top left), 
phalloidin-stained actin (red, top right), filipin-labelled cholesterol (blue, bottom left) and the 
merged image (bottom right). The image is representative of the majority of phagocytic 
events in three representative 4 h experiments. Scale bar indicates 10 μm. 
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Figure 4.6. Cholesterol independent internalisation of live FITC-labelled E. coli into 
a THP-1 monocyte. FITC-labelled bacteria (green, top left), phalloidin-stained actin (red, 
top right), filipin-labelled cholesterol (blue, bottom left) and merged image (bottom right). 
This image is representative of the majority of phagocytic events in three representative 4 h 
experiments. Scale bar indicates 10 μm. 
 
FITC-labelled Map (live and formaldehyde-killed) uptake by THP-1 cells was analysed 
using the same parameters. The results showed cholesterol aggregated at the site of 
entry of the majority of both live and formaldehyde-killed Map bacteria observed 
(Figures 4.7 and 4.8) and are concordant with the flow cytometry data (Figures 4.3 
and 4.4).  
 
Collectively, these results suggest that the majority of Map are internalised via a 
cholesterol-dependent process, at areas of the plasma membrane enriched for 
cholesterol. Furthermore, the observation that formaldehyde-treatment of Map had 
no significant effect on uptake suggests involvement of a Map cell wall component in 
this process, unaffected by cell fixation, rather than an active process. These findings 
do not rule out cholesterol independent uptake of Map into THP-1 cells, as uptake 
was not completely abrogated with cholesterol removal.  
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Figure 4.7. Cholesterol aggregation at the site of internalisation of live FITC-
labelled Map into a THP-1 monocyte. FITC-labelled bacteria (green, top left), phalloidin-
stained actin (red, top right), filipin-labelled cholesterol (blue, bottom left) and the merged 
image (bottom right). The image is representative of the majority of phagocytic events in 
three representative 4 h experiments. Scale bar indicates 10 μm. 
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Figure 4.8. Cholesterol aggregation at the site of internalisation of formaldehyde-
killed, FITC-labelled Map into a THP-1 monocyte. FITC-labelled bacteria (green, top 
left), phalloidin-stained actin (red, top right), filipin-labelled cholesterol (blue, bottom left) 
and merged image (bottom right). This image is representative of the majority of phagocytic 
events in three representative 4 h experiments. Scale bar indicates 10 μm. 
 
 
4.2.2 Map associates with cholesterol rich areas inside THP-1 cells 
 
To determine whether Map continued to associate with cholesterol-rich 
compartments at 48 h post infection, cells were cultured and incubated in 
cholesterol-depleting agents (simvastatin and MβCD) before being stained with 
filipin, washed and resuspended in 10 μl of AF1 antifade solution, (Citifluor, London, 
England). Ten microlitres of the cell suspension was aliquoted onto a microscope 
slide, covered with a cover glass, and sealed with nail polish (L’Oreal).  
 
This experiment showed live Map bacteria in compartments with cholesterol-rich 
membranes 48 h post infection. Moreover, bacterial density within the compartment 
appeared to affect cholesterol aggregation. In cells with 3 or more Map bacteria, 
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comparatively large amounts of cholesterol aggregated around bacteria containing 
compartments (Figure 4.9). A similar effect was also observed in cells co-incubated 
with formaldehyde- and heat-killed Map (not shown).  
 
 
 
Figure 4.9. Live Map bacteria and cholesterol co-localisation. FITC-labelled live Map 
(green) and filipin-labelled cholesterol (blue) co-localisation within THP-1 cells. Images show 
(Top row) a single bacterium, (Middle row) Several bacteria and (Bottom row) large 
aggregations of bacteria associated with cholesterol-rich areas of the cell. Scale bar indicates 
10 μm.  
 
 
To visualise the association between Map and cholesterol inside the cell in more 
detail, confocal microscopy was used to collect optical sections through THP-1 cells 
co-incubated with Map, and 3D models of the cells constructed. Cells were exposed 
to FITC-labelled Map for 48 h, then washed and stained with filipin. After washing to 
remove excess stain, cells were resuspended in AF1 antifade solution and imaged by 
confocal microscopy (Leica model SP5, Wetzlar, Germany) with a 40x oil-immersion 
NA 1.3 lens using optical step size of 500 nm. Filipin was excited at 405 nm light 
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(violet) and emission collected at 460 nm, while FITC was excited with 488 nm (blue) 
light and fluorescence collected from 500-550 nm. Live Map bacteria residing in 
cholesterol-rich areas of the cell were visualised using this approach. Optical sections 
were converted into 3-dimensional models of the infected cells (Figure 4.10). 
 
 
 
Figure 4.10. Three dimensional model of Map and cholesterol.  A section through a 
Map containing cell with labelled cholesterol (white) and live Map (blue). The 3D model can 
be viewed on the University of Canterbury confocal website - link.  
 
 
4.2.3 Effect of cholesterol depletion on lysotracker co-localisation 
 
To investigate whether cellular cholesterol depletion had an effect on phagosomal 
acidification to 48 h post infection, THP-1 cells were exposed to Map (MOI 50:1) for 
4 h with and without simvastatin (2.5 µg/ml), then washed three times with media 
and incubated for a further 48 h in media with and without simvastatin. At 48 h, the 
number of Map co-localising with acidic areas of the cell was compared between 
simvastatin treated and untreated cells using lysotracker as described previously (p 
36, section 3.2.1). No significant difference in phagosome acidification was found 
between simvastatin treated- and untreated cells (Figure 4.11).  
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Figure 4.11. Effect of simvastatin on lysosome co-localisation of live labelled Map. 
The intensity of lysotracker staining was compared between Map in untreated and 
simvastatin treated cells. Values are mean +/- SEM from three independent experiments. No 
significant difference was seen at 48 h post infection (Data was analysed using a one way 
ANOVA).  
 
 
4.2.4 Cholesterol and the long term survival of Map 
 
To determine the effect of cholesterol on the intracellular processing and, therefore, 
the survival of Map in human monocytes over longer times, bacteria were co-
incubated with THP-1 cells with and without pre-treatment with 2.5 μg/ml 
simvastatin. Duplicate THP-1 cell cultures were seeded at 100,000 cells/ml, and 
incubated with Map (MOI 50:1). The medium (with or without simvastatin) was 
changed every 2 days, and the cells were split to prevent cell overgrowth at 7 and 12 
days. At 2, 7 and 14 days post infection, duplicate 100 μl aliquots were taken from 
each sample, cytospun onto microscope slides and stained with the mycobacteria-
specific ZN stain (Appendix 1). The number of cells with visible intracellular Map was 
counted in triplicate (3 x 100 cells per treatment per time point) using light 
microscopy. All counts were carried out blinded. 
 
This experiment showed no significant difference in the number of Map in 
simvastatin-treated and untreated cells at 2 days.  However, at 7 and 14 days, there 
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were fewer intracellular bacilli in simvastatin-treated cells compared to the untreated 
controls, although these differences were not significant (Figure 4.12).  
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Figure 4.12. THP- cells containing Map bacteria after extended incubation. The 
percentage of THP-1 monocytes containing Map bacteria was determined in the absence and 
presence of simvastatin (2.5 μg/ml). Values are mean +/- SEM from three independent 
experiments. Although there were observably fewer Map bacteria in simvastatin treated cells 
at 1 and 2 weeks post infection, no significant difference was found between treated and 
untreated cells (data was analysed using a two way ANOVA). 
 
 
To elucidate whether simvastatin treatment was associated with a reduction in live 
Map and not simply reduced bacterial staining under these conditions, intracellular 
Map were enumerated by plate counts. Aliquots (1 ml) of the cell suspension were 
collected at days 2, 7 and 14. The cells were washed twice in PBS containing 2.5 % 
FBS (PBS/FBS), then resuspended at 250,000 cells/ml in PBS/FBS before being split 
into two equal aliquots. The cell in one tube were resuspended in PBS with 0.1 % 
Triton X-100, vigorously vortexed and incubated for 10 min at 37oC to ensure cell 
lysis before the addition of amakacin (an aminoglycocide antibiotic, final 
concentration 200 μg/ml). In contrast, amakacin was added to the second tube (final 
concentration 200µg/ml) prior to cell lysis, to kill extra-cellular bacteria (Patel et al., 
2006). After 2 h incubation at 37oC, the cells were washed three times with PBS/FBS 
before being lysed.  Both lysates were serially diluted and plated on 7H9 agar. After 
a minimum of 5 weeks incubation at 37oC, colonies on the plates were counted. 
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Viable intracellular bacteria were determined and normalised to colony forming units 
(CFUs) per 100,000 cells for each dilution. For each experiment, normalised results 
for each dilution were averaged, and then combined to give one replicate value. Any 
colonies found growing on the control plates were, counted, combined, and then 
subtracted from replicates to give the final number of intracellular bacteria (Figure 
4.13).  
 
Concordant with light microscopy findings, fewer viable Map were recovered from 
simvastatin-treated cell preparations than untreated controls at 1 and 2 weeks post 
infection. However, these differences were not significant. 
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Figure 4.13. Map CFU’s after incubation with control and simvastatin (2.5μg/ml) 
treated cells to two weeks post infection. Map bacteria were plated at three dilutions. 
These were adjusted to CFUs per 100K cells, and combined to give one replicate value. 
Values are mean +/- SEM from three independent experiments. Although there were fewer 
viable Map bacteria in simvastatin treated cells at 1 and 2 weeks post infection, no significant 
difference between was found between treated and untreated cells (data was analysed using 
a two way ANOVA). 
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4.3 Discussion 
 
The work presented here shows for the first time that Map uptake and survival is 
associated with cell membrane cholesterol. Map associate with and are internalised 
into THP-1 monocytes in a cholesterol-dependent manner. They are found to persist 
in cholesterol-rich compartments two days post infection, and their ability to persist 
inside THP-1 cells is cholesterol-dependent.  
 
Cholesterol has been implicated in many aspects of bacterial and mycobacterial 
pathogenesis. Uptake via a cholesterol-dependent pathway increases the survival of 
many intracellular pathogens including M. tuberculosis (Martens et al., 2008; Miner 
et al., 2009; Naroeni and Porte, 2002) but the mechanism(s) involved are largely 
unknown. Evidence of a cholesterol specific receptor (Ck) on the surface of M. 
tuberculosis implies bacterial binding directly with membrane cholesterol (Kaul et al., 
2004). Cholesterol-mediated uptake reportedly circumvents the oxidative burst 
(Lamberti et al., 2008; Rodriguez et al., 2001), a potent antibacterial mechanism that 
might otherwise kill the intracellular bacteria. It is also hypothesised that by entering 
via cholesterol-rich areas, pathogens traffic only as far as endosomal compartments 
and are spared from undergoing lysosomal degradation (Naroeni and Porte, 2002; 
Rodriguez et al., 2001). In addition to direct advantages such as a supplemental 
carbon source and phagosome remodelling, cholesterol-rich intracellular membranes 
are intrinsically resistant to fusion with lysosomes. This is attributed, in part, to 
Rab 7, which remains in an inactive form in cells treated to increase intracellular 
cholesterol concentrations (Huynh et al., 2008). 
 
Mycobacterial persistence inside the host cells is also facilitated in part by association 
with cholesterol-rich areas in the cell. Depleting the cellular cholesterol of M. avium-
containing macrophages results in a stimulation of phagosomal maturation, leading 
to increased fusion of compartments with lysosomes (de Chastellier and Thilo, 2006). 
M. tuberculosis induce accumulation of cholesterol in macrophages (Kurup and 
Mahadevan, 1982), and reside in cholesterol-rich areas in these cells. Hyper-
cholesterolemic mice fed a cholesterol rich diet are extremely susceptible to 
M. tuberculosis infection. These animals exhibit severe pathology, a greatly increased 
bacterial load and significantly decreased survival compared with their wild type 
counterparts (Martens et al., 2008). 
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Intracellular cholesterol is shown to assist the persistence of pathogenic 
mycobacteria by several different mechanisms. There is evidence that 
M. tuberculosis accumulate cellular cholesterol in the free-lipid zone of their cell wall, 
even when there are other carbon sources available (Pandey and Sassetti, 2008). 
Furthermore, when deprived of a carbon source, M. tuberculosis is able to 
metabolise this cholesterol (Brzostek et al., 2009; Miner et al., 2009), a trait that is 
likely to be highly advantageous in the nutrient-deficient environment of the 
phagosome.  
 
In this study, a proportion of the Map-containing compartments were observed to 
stain positive for the cell membrane protein TACO, a late endosomal protein that is 
also reportedly retained on the phagosomes of pathogenic mycobacteria. TACO is 
implicated in attenuating the fusion of the mycobacterium-containing compartments 
with lysosomes (Kaul et al., 2004), and related studies show M. tuberculosis and 
M. bovis secrete a coronin-interacting protein that is dependent on cholesterol in its 
interaction with cellular TACO (Deghmane et al., 2007). Interestingly, the cholesterol 
receptor found on M. tuberculosis also up-regulates transcription of the TACO protein 
in infected cells (Kaul et al., 2004). It is unclear at this stage whether the association 
of TACO with Map-containing phagosomes shown here is a result of cholesterol 
accumulation in the compartment, or whether it is actively retained on Map 
containing phagosomes.  
 
Long term persistence of pathogenic mycobacteria in host cells is associated with an 
altered bacterial phenotype, demonstrated by the emergence of spheroplast (or cell 
wall deficient) forms after extended intracellular incubation. These forms lack many 
cell wall components (Hines and Styer, 2003), which may enhance bacterial survival 
by reducing antigenicity (Chandler and Hamilton, 1975). In the following chapter, the 
morphology of Map to inside monocytes is followed over time.  
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Chapter 5. Map bacterial morphology 
during long term survival  
 
5.1 Introduction 
 
Mycobacteria are some of the most persistent pathogens known, with a third of the 
human race thought to be latently infected with M. tuberculosis (Gatfield and Pieters, 
2000). In the short term, these bacteria have evolved to manipulate the host 
phagosome in order to persist inside host cells. However, longer term persistence, 
especially in chronic infections, is less well characterised.  
 
Pathogenic mycobacteria are renowned for their ability to circumvent the host cell’s 
immune response, and to persist within professional phagocytes via many different 
mechanisms (Nguyen and Pieters, 2005). Many bacteria adopt a viable but non-
culturable form that is specialised for an intracellular existence (Beran et al., 2006). 
The development of an intracellular bacterial phenotype has been implicated in the 
persistence of some mycobacterial species (Bermudez et al., 2004).  
 
Many species of bacteria and some mycobacteria (including M. tuberculosis) can 
develop these cell wall deficient (CWD) forms. More commonly known as 
spheroplasts, these bacteria are often characterised by a change in cellular shape, 
most commonly from rod-shaped to round (Beran et al., 2006). By discarding their 
cell wall, it is thought that they lose much of their antigenicity, allowing them to “fly 
under the radar” of the intracellular immune response (Rinno et al., 1980). 
Consequently, spheroplasts have been implicated in the aetiology of numerous 
diseases, including Crohn’s disease (Beran et al., 2006; Chiodini et al., 1986; Willet 
and Thacore, 1967). However, it is unclear if they have a role in disease, or if they 
are a form that facilitates persistence in nature (Mattman, 2001).   
 
This question is particularly relevant to many mycobacterial diseases, where 
spheroplasts are often found (Beran et al., 2006). Spheroplasts are a form of Map 
not documented in ruminant Johne’s disease. They have, however, been identified 
by long term culture in the white blood cells, breast milk, and intestinal biopsies of 
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patients with CD (Beran et al., 2006; Cho et al., 1986; Hines and Styer, 2003; Moss 
et al., 1992; Naser et al., 2004). However, whether CWD forms of Map are actively 
involved in infection and disease remains unknown, and is still a subject of much 
debate.  
 
Spheroplast forms are fastidious and extremely slow growing, with cultivation taking 
months or years (Chiodini et al., 1986). Furthermore, they require specific protoplast 
media for extended growth and rapidly revert to their bacillary (cell wall competent) 
forms when grown on conventional media (Markesich et al., 1988). In 2003, the first 
chemical method to generate Map (strain 19698) spheroplasts in culture was 
published. This study also analysed the chemical and structural constituents of the 
generated spheroplasts. Significant attenuation of cell wall features integral for 
diagnosis, virulence, pathogenicity, immunological response and spectrum of disease 
were reported (Hines and Styer, 2003). This technique provides a means to shed 
light on some of the mystery surrounding a role for spheroplasts in Map 
pathogenesis. 
 
The following experiments investigated whether spheroplasts could be chemically 
generated from Map strain Dominic. In addition, THP-1 monocytes infected with Map 
were cultured for up to 5 weeks to explore whether Map developed a spheroplast-
like form as a result of long term infection. A combination of light and transmission 
electron microscopy (TEM) was used to visualise differences in bacterial morphology 
and ultrastructure following chemical treatment and/or long term intracellular 
culture. 
 
5.2 Results 
 
5.2.1 Chemical generation and visualisation of spheroplasts 
 
 
To visualise the bacteria with light microscopy, a 10 µl aliquot of bacterial suspension 
was spread and heat fixed to a microscope slide before ZN staining (Appendix 1). 
Concurrent with previous studies (Hines and Styer, 2003), light microscopy showed 
that Map bacteria change their morphology after chemical treatment (p11, section. 
2.12). In addition to long rod-shaped bacilli, shorter rod shapes and acid-fast coccoid 
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forms were seen after 14 days. Furthermore, the propensity of Map bacteria to form 
large clumps during culture appeared to be affected by the chemical treatments, 
demonstrated by an observable decrease in the number of large clumps of Map at 
this time (Figure 5.1).  
 
 
 
Figure 5.1. Chemically generated spheroplasts by light microscopy. Map bacteria 
treated with the spheroplast generating protocol were stained with ZN stain at 0 (A), and 14 
days culture (B). Note the rounded but acid fast forms at 14 days compared with day 0 
(arrows). Scale bar indicates 10 μm. 
 
 
Negative-staining transmission electron microscopy was used to examine in more 
detail the morphological changes associated with chemical treatment of Map. First, a 
5 μl aliquot of bacterial suspension was aliquoted onto formvar film, copper mesh 
grids (ProSciTech, Thuringowa Central, Queensland, Australia) and allowed to 
adhere. Adherent bacteria were stained with 2 % phosphotungstic acid (PTA) for 1 
h. Grids were washed twice with Pipes buffer (60 mM pH 6.8) to remove excess 
stain, then imaged on a CM 12 scanning-transmission electron microscope (Phillips).  
 
Examination of treated and untreated Map revealed densely-stained bacillary forms 
of various sizes (Figures 5.2A, B), as well as several translucent coccoid forms (figure 
5.2D). In addition, intermediate forms were also observed. These were roughly 
coccoid, with what appeared to be cell wall material being sloughed off (Figure 
5.2C). This observation could also suggest the presence of pseudo-spheroplast 
  A B 
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forms, with partial loss of their cell wall. The translucent, coccoid-shaped forms 
(figure 5.2D) lacked the opaque consistency of bacillary forms, which may be 
indicative of a lost cell wall. Protrusions were seen on both opaque rods and 
translucent coccoid forms. These may be microspherules, which are reportedly an 
indicator of metabolic activity (Chiodini et al., 1986). If so, it would suggest that 
these chemically-generated spheroplast forms of Map may remain viable even after 
cell wall removal (Figures 5.2B,D, arrows). 
 
 
 
Figure 5.2. Chemically generated spheroplasts by transmission electron 
microscopy. Images are untreated bacillary Map (A, B), and chemically treated Map (C,D). 
The untreated mycobacterial suspension shows the typical bacillary form, with the opaque 
staining suggesting the presence of the characteristic thick cell wall. In the treated 
mycobacterial suspensions, intermediate forms were also observed in addition to bacilli. 
These forms appeared to have lost their rod morphology but retained the dense cell wall 
material (C). Translucent coccoid forms were also present (D). Scale bars indicate 1 µm. 
 
 
A B 
C D 
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Ultrastructural differences in the bacteria were examined using modifications to 
established methods (Day 1995, Appendix 5). Briefly, bacteria were fixed in 2.5% 
gluteraldehyde for 1 h at room temperature, then washed twice and resuspended in 
50 μl of 3% liquid agarose (warm). The bacteria/agarose solution was mixed gently 
by pipetting up and down, then aliquoted onto a microscope slide and left to set. 
Bacteria-rich areas of the agarose (plugs) were cut out of this agarose smear and 
transferred to an eppendorf tube. Plugs were stained, dehydrated and blocked in 
resin as described previously (Day, 1995, Appendix 6). Blocks were cut into 70 nm 
slices using an EM-UC6 microtome (Lecia), mounted on formvar film, copper mesh 
grids and imaged. (Day, 1995)        
Examination of treated bacteria revealed short rods typical of Map bacilli. These were 
approximately 1 μm in length, with a width of between 300 and 500 nm. Longer 
forms up to 1.5 μm in length were also observed. Map bacilli contained an electron 
dense cytoplasm, with numerous internal structures, as reported by (Hines and 
Styer, 2003). The characteristic double cell wall was visualised, however only in a 
small proportion of bacteria (Figure 5.3A, arrow). In others, this wall could only be 
visualised as a halo around the bacterium, as reported in studies of M. avium (Frehel 
et al., 1991) (Figure 5.3B, arrow). Considerably fewer bacillary Map were observed 
among the chemically-treated bacteria (Figure 5.3C,D). Instead, the majority of 
forms were found to be amorphous or coccoid, with notably less electron dense 
internal structure than untreated bacilli. Bacilli that were still present were elongated 
or showed atypical rod morphology suggestive of transition to the coccoid form 
(Figure 5.3C, arrow). Despite poor camera resolution, there was evidence that the 
majority of chemically-treated bacteria more closely resembled spheroplast than 
bacillary forms, similar to findings reported elsewhere (Markova et al., 2008b; Udou 
et al., 1982).  
 
The loss of cell wall in the treated bacteria was not confirmed.  However, the 
differences in morphology seen by ZN staining, the presence of translucent forms 
seen by grid-TEM, and the similarity of these forms to spheroplasts generated from 
other mycobacterial species (Yabu and Takahashi, 1977), suggest cell wall deficient 
forms of Map strain Dominic are generated after 14 days of chemical treatment.      
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Figure 5.3. Chemically generated spheroplasts by transmission electron 
microscopy. Images are untreated Map showing characteristic rod morphology and double 
cell wall (A,B), Map bacilli treated for 14 days to generate spheroplasts, bacteria have lost 
their electron dense cytoplasm and rod shaped morphology (C,D). Transmission electron 
micrographs of Map spheroplast forms isolated from a CD patient (note the membrane 
protrusion similar to that seen in figure 5.2E) (E- image adapted from (Chiodini et al., 1986)), 
and chemically generated spheroplasts of M. smegmatis (F- image adapted from (Yabu and 
Takahashi, 1977). Scale bars indicate 200 nm (B, D), 500 nm (A, C, E) and 1 μm (F).  
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5.2.2 Bacterial morphology after long term infection 
 
For long term co-incubation experiments live Map bacteria were added to 200,000 
THP-1 cells at an MOI of 100:1. Media was changed every 2 days, and the cells were 
split (with 25% retained) every 7 days to prevent overgrowth. After 1 and 5 weeks 
of co-incubation, a 100 µl aliquot of cells was cytospun, then heat fixed to a 
microscope slide and ZN stained (Appendix 1). One ml of cell suspension was 
resuspended in 2.5% gluteraldehyde and processed for electron microscopy 
(Appendix 5). The morphology of ZN positive forms inside the cells was analysed by 
light microscopy, while the ultrastructure of cells and bacteria was analysed using 
electron microscopy.  
 
Intracellular Map, as detected by ZN staining, were predominantly bacillary after one 
week. However, at 5 weeks post infection, ZN positive forms inside the cells were 
exclusively spherical, and varied in size from approximately 0.5 to 1.5 μm (Figure 
5.4).  
 
 
 
Figure 5.4. ZN positive organisms in THP-1 cells at 1 and 5 weeks. Representative 
ZN-positive forms after incubation of Map bacteria with THP-1 monocytes at 1 (A) and 5 (B) 
weeks post infection. Scale bar is 10 µm. 
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Intriguingly, the spherical forms observed in the 5 week cultures closely resemble 
ZN-positive structures observed following the culture of peripheral blood taken from 
patients with Crohn’s disease (John Aitken, unpublished results), with the larger size 
(approximately 3-4 μm) of some forms found in CD patient blood the only observable 
difference (Figure 5.5). 
 
 
 
Figure 5.5. Comparison of ZN positive forms in THP-1 and CD patient cells. 
Spherical, ZN positive forms inside THP-1 monocytes after 5 weeks incubation with Map 
(left), and similar forms in cytospun peripheral blood of a CD patient. Scale bar indicates 10 
µm. 
 
 
Using transmission electron microscopy, bacteria resembling bacillary Map were seen 
inside THP-1 cells at 1 week post infection (Figure 5.6D, arrows). These bacteria 
displayed similar morphology and ultrastructure to Map bacilli analysed previously 
(Hines and styer et al 2003). In addition, amorphic/coccoid forms were also observed 
in the Map-exposed cells (Figure 5.6C, arrow). Many of these forms were bounded 
by electron light space (Figure 5.6C, arrow), suggesting they were in membrane 
bound compartments. Some, however, were not (Figure 5.6E, white arrow). The 
intracellular structure was homogeneous in most forms, with several 
organelles/vesicles visible in some (Figure 5.6E, black arrow). 
 
Whether these forms are organelles generated by the presence of bacteria in the 
cell, or whether they are Map bacteria in an intracellular form is unknown. However, 
the morphology and interior structures shown here are similar to the cell wall 
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deficient form of M. bovis BCG, which was recently shown to develop into a 
spheroplast form after an extended incubation period in the peritoneal cavity of 
guinea pigs (Figure 5.6F). While viability cannot be inferred from TEM, the close 
apposition of the phagosomal membrane to bacteria (Figure 5.6D, arrow), is often 
seen in phagosomes containing live mycobacteria (de Chastellier, 2009).  
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Figure 5.6. Map inside THP-1 monocytes at 1 week post infection (TEM). (A) 
bacteria-free control cells, (B-F) Map-exposed THP-1 monocytes, containing intracellular 
bacteria, and bacteria-like forms of various morphology (B-E), (F) an M. bovis BCG derived 
spheroplast, after incubation inside a Guinea pig peritoneal macrophage (image adapted from 
(Markova et al., 2008a)). Scale bars indicate 5 μm (A), 2 μm (B, C, D) and 500 nm (E, F). 
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No bacillary forms were seen in THP-1 cells at 5 weeks post infection, but similar 
amorphic/coccoid forms were present in many cells (Figure 5.7). These spheroplast-
like forms were larger than those seen at the one week time point but exhibited the 
same homogeneous internal architecture. Interestingly, they were a similar size to 
the ZN positive forms observed in the peripheral blood of a CD patient (Figure 5.5), 
and also exhibited ultrastructural characteristics (such as a homogeneous interior) 
similar to that of spheroplasts generated chemically from other mycobacteria such as 
M. bovis and M. smegmatis (Figures 5.6F, 5.7F). These coccoid forms were mostly 
present in what appeared to be membrane bound compartments, but several were in 
the process of phagocytosis, confirmed by the presence of a phagocytic cup (Figure 
5.7C, arrow). There was also some evidence of a double membrane, bounding these 
forms (Figure 5.7E, arrow), similar to that reported for M. smegmatis bacteria after 
treatment to remove their cell wall (Udou et al., 1982) (Figure 5.7F, arrow). This is 
intriguing, as no such structure was seen at 1 week post infection. The presence of a 
double membrane could indicate reversion of a spheroplast form to a ZN positive 
form.  
 
In sharp contrast to the Map exposed THP-1 cells, many of the bacteria-free cells 
were apoptotic, showing nuclear condensation, shrinking and cytoplasmic 
vacuolization typical of monocyte apoptosis (Lang et al., 2002) (Figure 5.7A). 
Inhibition of apoptosis has been reported for pathogenic mycobacteria inside host 
cells. It is thought that by inhibiting the apoptotic pathways in host cells, these 
bacteria extend the life of their host cell, prolong their intracellular stay, and 
therefore maximise replication time (Berger and Griffin, 2006; Hasan et al., 2006). 
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Figure 5.7. Spheroplast like forms in Map exposed cells at 5 weeks post infection 
by transmission electron microscopy. (A), bacteria free cells, (B-E) cells with atypical 
forms inside and (F) a chemically generated M. smegmatis spheroplast, showing cell wall 
exfoliation from the membrane (Image adapted from (Udou et al., 1982)). Scale bars indicate 
5 μm (A, B, D), 2 μm (C) and 200 nm (E, F). 
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5.3 Discussion 
 
This study demonstrated that, as with other mycobacteria, spheroplasts could be 
generated chemically from Map strain Dominic. This confirms that the technique 
developed by Hines and Styer (2003) is potentially applicable to many strains of Map. 
Furthermore, experiments showed that coccoid forms, not present in control cells, 
existed in Map exposed THP-1 monocytes at 1 and 5 weeks post infection. Coccoid 
forms observed at 5 weeks post infection showed similarities to chemically generated 
spheroplasts. In addition, they were of a similar size to ZN positive forms found in 
THP-1 monocytes at 5 weeks post infection by light microscopy, as well as in CD 
patient peripheral blood cells. Interestingly, in contrast to the coccoid forms in THP-1 
monocytes observed at 1 week, forms at 5 weeks incubation showed evidence of a 
double membrane, indicative of a mycobacterial cell wall. This is an intriguing 
connection to the ZN positive forms seen in CD patient blood cells. (Hines and Styer, 
2003) 
These observations support the possibility that a proportion of Map may loose all or 
part of their cell wall and develop a spheroplastic, intracellular phenotype after 
prolonged intracellular incubation. Map spheroplasts, such as the translucent bacteria 
visualised by negative staining TEM, may not have a cell wall. If so, these forms may 
not be acid fast. This has implications for detection using conventional mycobacterial 
screening techniques such as ZN staining (Sechi et al., 2004). 
 
Spheroplast forms of mycobacteria are regularly documented in mycobacterial 
infection and are implicated in a variety of diseases (Beran et al., 2006). An L-form 
of M. tuberculosis develops in rat macrophages after 5 weeks incubation and is more 
drug tolerant, and faster growing than the bacillary form (Markova et al., 2008a; 
Markova et al., 2008b). Spheroplast forms of M. tuberculosis (Beran et al., 2006; 
Markova et al., 2008a; Thacore and Willett, 1966), M. bovis (Markova et al., 2008b) 
and M. smegmatis (Udou et al., 1982) have also been characterised. Spheroplast 
forms of Map, confirmed by genetic analysis and reversion to the bacillary form, have 
also been isolated from CD patient blood and tissue in several different studies 
(Chiodini et al., 1986; Hines and Styer, 2003). Given the difficulties inherent in 
isolation, how these forms occur and whether they have a role in CD remains 
unclear. The results presented in this chapter support the possibility that Map 
spheroplasts may develop after prolonged intracellular persistence. While this idea is 
 86
thought-provoking, further research is required to determine the true nature of these 
forms. Specifically, are they organelles produced after prolonged culture in Map 
exposed cells, or an intracellular form of Map? 
 
Given the frequent splitting of cells and media changes, the length of culture, and 
the low number of samples analysed, the potential for the presence of other factors 
is significant. To confirm if the forms found inside THP-1 monocytes after an 
extended incubation are Map, or whether they are simply cellular structures brought 
about by the extended culture period and bacterial exposure, more research is 
needed. A mycobacteria- or Map-specific proceedure such as FISH could be used for 
this purpose. Another approach could be to label Map exposed cells with a gold-
labelled, (non-cell wall) mycobacteria specific antibody, then process and image as 
above using TEM. These experiments are beyond the scope of this study. Therefore 
the above concerns must be kept in mind, and any interpretation of the results 
presented in this chapter must be made with caution. 
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Chapter 6. General Discussion 
 
6.1 Manipulation of the phagocytic pathway 
 
Evidence is emerging that Map bacteria are able to persist in human cells as they do 
in murine and bovine macrophages (Rumsey et al., 2006). However, there are few 
studies investigating the interaction(s) of Map bacteria with human cells (Britton et 
al., 1994; Rumsey et al., 2006). This study has shown that Map behaviour in THP-1 
monocytes mimics that of M. bovis. Moreover, the mechanisms of Map uptake and 
persistence in these cells show intriguing similarities to pathogenic bacteria and 
mycobacteria. 
 
The role of cell wall components in the fate of Map in host cells remains unclear at 
this stage. The observation that formaldehyde-killed Map were also taken up into 
THP-1 cells via a cholesterol-mediated process (Chapter 4) suggests this uptake may 
be a passive process, mediated by cell wall constituents. Cell wall molecules of other 
mycobacteria have previously been shown to affect fate after phagocytosis. Mannose 
receptor-dependent uptake facilitates the development of a safe intracellular niche 
for M. tuberculosis. It is not, however, known whether this, or similar pathways or 
molecules exist for other mycobacteria (Kang et al., 2005).    
 
Cell wall components also affect pathways inside host cells. Mannosylated 
lipoarabinomannan (ManLAM) is a cell wall component from slow growing 
mycobacterial species such as M. tuberculosis and M. bovis. It is integral in mediating 
bacteria/host interactions (Rojas et al., 2000), with evidence that ManLAM from 
these species is able to inhibit macrophage activation as well as apoptosis (Chan et 
al., 2001; Sibley et al., 1990). Interestingly, long-term Map colonisation of THP-1 
monocytes also appeared to inhibit cellular apoptosis (p76, section 5.2.2). However, 
more research is needed to qualify this observation. 
 
Lipid rafts are cholesterol-rich areas within cell membranes (Goluszko and Nowicki, 
2005). Cholesterol is integral to raft formation because removal (with compounds 
such as methyl-β-cyclodextrin) results in a disassociation of the raft as a whole, as 
well as the disassociation of proteins from raft domains (Christian et al., 1997; 
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Lawrence et al., 2003). Many pathogenic microbes (bacteria, viruses) use lipid raft-
dependent processes to augment their pathogenesis (Shin and Abraham, 2001; Zass 
et al., 2005). The cholesterol dependent uptake and fate of Map in THP-1 cells 
suggests a role for lipid rafts or lipid raft signalling.   
 
Lipid rafts domains are also found on endosomal membranes inside cells, meaning 
their effects extend beyond internalisation (Rosenberger et al., 2000; Zass et al., 
2005). The association between Map and lipid rafts is strengthened by the 
observation that Map and M. bovis reside in cholesterol-rich areas inside the cell 48 h 
post-infection. Other pathogenic bacteria, including Salmonella typhimurium and M. 
bovis also traffic to areas of the cell that are rich in cholesterol (Catron et al., 2004; 
Harrison et al., 2004; Sun et al., 2007). It is thought that this cholesterol facilitates 
the formation of these membrane micro-domains or rafts, which aid in manipulation 
of cell signalling and processing (Catron et al., 2004). In addition, there is also 
evidence that these cholesterol-rich domains are intrinsically resistant to fusion with 
lyosomes. This effect is thought to be mediated by inactivation of Rab 7 (Huynh et 
al., 2008).  
 
In THP-1 cells, both Map and M. bovis phagosomes exhibit strong Rab 7 staining 48 
h post infection. Rab 7 is a marker of late phagosomes; the active, GTP-bound form 
is instrumental for the fusion of pathogen-containing compartments with lysosomes 
(Vieira et al., 2002), while there is evidence that conversion of Rab 7 to the inactive 
GDP-bound form inhibits phagosomal maturation (Sun et al., 2007). 
 
Some pathogenic bacteria secrete factors that inactivate Rab 7 on nearby 
phagosomes. This results in the extended association of Rab 7 with phagosomes, 
and decreased fusion of the compartments with lysosomes (Sun et al 2007). 
Lipoamide dehydrogenase, the enzyme responsible, is secreted by M. tuberculosis 
and M. bovis, but not by the non-pathogenic M. smegmatis (Deghmane et al., 2007). 
Given the similarities between Map and M. bovis trafficking shown here, the potential 
exists for Map to also resist fusion of the phagosome with lyosomes via inactivation 
and retention of Rab 7.  However, this hypothesis remains to be tested. 
 
Recent studies in other cell systems suggest that cholesterol and Rab 7 may be 
interlinked. Lysosomal degradation of low density lipoprotein (LDL), a major source 
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of exogenous cholesterol, is under the control of Rab 7 in aortic cells (Bruckart et al 
2000). In thyroid cells, treatment with lovastatin (an analogue of simvastatin) up-
regulates Rab 7 expression (Bruckert et al., 2000). These studies suggest that the 
inactivation of Rab 7 by pathogens such as M. bovis, Salmonella typhimurium and M. 
tuberculosis may occur through dual mechanisms; cholesterol aggregation, as well as 
direct Rab 7 inactivation by lipoamide dehydrogenase (Deghmane et al., 2007; 
Harrison et al., 2004; Sun et al., 2007). Despite these links, the connection between 
bacteria-containing phagosomes, cholesterol and Rab 7 has yet to be fully 
elucidated. 
 
A further dimension to this story was added with the discovery of the TACO protein. 
TACO is a leucocyte-specific, intracellular protein, shown to facilitate the persistence 
of pathogenic mycobacterial species in host cells (Anand and Kaul, 2005; 
Jayachandran et al., 2008; Jayachandran et al., 2007; Kaul, 2008). It was recently 
shown that the retention of the TACO protein on mycobacteria-containing 
phagosomal membranes is dependent on cholesterol (Deghmane et al., 2007). Map’s 
association with TACO has not been documented previously. However, TACO’s 
association with Map-containing phagosomes suggests another mechanism by which 
Map bacteria may persist in human cells.  
 
Simvastatin-mediated depletion of cellular cholesterol had no effect on Map viability 
or clearance 48 h post-infection. However at 1 and 2 weeks post infection, less Map 
were observed (by light microscopy and plate counts) in cells treated with 
simvastatin. Similar research suggests cholesterol acquisition is less important for 
early M. tuberculosis infection in mice. M. tuberculosis with a (genetically) impaired 
cholesterol uptake pathway, showed no difference in virulence and survival in the 
early stages of infection. However at later time points (4 weeks), these bacteria 
showed significant growth inhibition compared to wild types, implicating a 
requirement for cholesterol in long term persistence and pathogenesis (Pandey and 
Sassetti, 2008). In addition, M. tuberculosis is thought to induce the differentiation of 
macrophages into foamy macrophages, characterised by their high lipid content. The 
increased concentration of lipids (including cholesterol) is thought to augment their 
persistence in granulomas (Peyron et al., 2008). 
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Cholesterol manipulation has been proposed as a novel therapy for chronic infection 
with organisms that use it to augment their pathogenesis (Pucadyil et al., 2004; 
Rosch et al., 2010). Reducing cholesterol-dependent entry of microbes into cells has 
also been shown to reduce survival of pathogens in several systems (including 
Brucella suis (Naroeni and Porte, 2002) and Bordetella pertussis (Lamberti et al., 
2008). The uptake and persistence of Map in THP-1 cells is mediated, at least in 
part, by cholesterol dependent mechanisms. Cholesterol depletion using statins or 
cyclodextrins may be a good candidate for research into Map infection of animals. 
 
6.2 Spheroplasts 
 
Many cases of clinically active TB are thought to be the result of reactivation of a 
latent infection, where actively growing organisms emerge from what was an 
apparently non-replicative state (Primm et al., 2000). The development of an 
intracellular phenotype is well documented for many species of mycobacteria 
(Bermudez et al., 2004). The culturability of Map bacteria decreases after 
intracellular passage (Bull et al., 2009), suggesting the induction of an non-culturable 
intracellular phenotype.  
 
Spheroplast forms of mycobacteria have been isolated after prolonged passage 
through host phagocytes (Chiodini et al., 1986; Hines and Styer, 2003; Markova et 
al., 2008a; Markova et al., 2008b). In addition, several studies have isolated 
spheroplast–like forms from CD patient tissue (Chiodini et al., 1986; Hulten et al., 
2000). Several theories exist as to how these forms could augment persistence. The 
loss of cell wall antigens is thought to allow the bacterium to escape immune 
detection, and reduce energy requirements, both of which would augment 
intracellular persistence. 
 
An ability to chemically generate spheroplast forms of Map strain Dominic, as 
demonstrated here, now provides a tool to investigate a role for cell wall deficient 
forms in the pathogenesis and persistence of mycobacterial infections. Specifically, 
these forms may be useful for investigating the potential for pathogenic interactions 
between cell wall deficient forms and human or animal cells.   
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6.3 Map and CD 
 
The involvement of Map in Crohn’s disease has been debated since Dalziell first 
reported pathological similarities to Johne’s disease in 1913 (Harris and Barletta, 
2001). The isolation of Map bacteria, as well as Map reactive T cells from a 
significant proportion of CD patients (Naser et al., 2004; Naser et al., 2000; Olsen et 
al., 2009), supports a role for Map in this disease. 
 
Several genes linked to CD are also involved with susceptibility to mycobacterial 
disease. Nramp-1 impairment has been linked to leprosy (Worobec, 2009), and 
Card15 is associated with increased susceptibility to Map infection in cattle (Pinedo et 
al., 2009). Functional studies of NOD-2, the first genetic element to be implicated in 
susceptibility to CD (Travassos et al., 2009), show that the CD associated NOD-2 
polymorphism impairs killing of bacteria (Perez et al., 2010). NOD-2 is involved in the 
recognition of Map bacteria by the innate immune system (Ferwerda et al., 2007), 
specifically, the CD associated polymorphism results in increased susceptibility to 
mycobacterial infection in mice (Divangahi et al., 2008).  
 
Isolating Map DNA from tissue requires specific extraction conditions. Several studies 
which showed no association between Map and CD (Cho et al., 1986; Heatley et al., 
1975; Sasikala et al., 2009) have been criticised for using inadequate techniques and 
conditions for extracting mycobacterial DNA (Feller et al., 2008). In addition, many of 
the drugs commonly used to treat the symptoms of CD (asothioprine, 6-
mercaptopurine and methotrexate) have significant, and specific effects on Map 
growth in vitro (Shin and Collins, 2008). Some hypothesise that these drugs are 
reducing the Map bacterial load, making detection of Map more difficult (Greenstein 
et al., 2007a; Greenstein et al., 2007b; Shin and Collins, 2008).  
   
Despite the substantial efforts to elucidate a possible pathogenic mechanism by 
which Map bacteria are able to participate in the aetiology of Crohn’s disease, the 
debate continues as to how this is able to occur without the overwhelming 
occurrence of bacilli that characterise bovine Johne’s and other MAP infections in 
animals. Many hypotheses exist to try and explain this discrepancy. Some 
researchers have theorised that Map bacilli could be “hiding out” in gut-associated 
lymphoid tissue or the lymph system (Pierce, 2009). Others have suggested that the 
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infective form of Map in humans is cell wall deficient, and therefore is unable to be 
stained using conventional mycobacterial staining techniques (Chiodini et al., 1986). 
Interestingly, ovine Johne’s disease is classified into two different forms. The first is 
a multibacillary disease with many ZN-positive Map in tissues and the characteristic 
widespread inflammation. The second form however, exhibits the same inflammatory 
symptoms, but few or no ZN positive bacilli can be found in the tissues (Smeed et 
al., 2007). Research into the aetiology of the differing forms of ovine Johne’s is 
limited at this stage, but the lack of ZN positive bacilli coupled with inflammatory 
symptoms suggests an interesting area of future research. 
 
6.4 Conclusions and future directions 
 
The inactivation of Rab 7 by pathogenic mycobacteria, leading to a failure to bind 
Rab 7-interacting lysosomal protein (RILP) is well characterised. Experiments to 
determine the activity of Rab 7 present on the phagosomes of live and killed Map are 
currently being prepared. 
 
Cholesterol has been shown to augment the persistence of many pathogenic species. 
However, many of its interactions with bacteria and host cells remain largely 
uncharacterised. In particular, its role in the short and long term survival of Map in 
human cells is far from understood. Much more research is needed to fully elucidate 
the role of cholesterol in Map infection. Given the precedence of cholesterol 
involvement in other pathogenic species, many techniques required to unravel its 
involvement are well developed and characterised. Given the growing awareness that 
cellular cholesterol is a major contributor to bacterial pathogenesis, it is likely that 
the inter-relationship between Map and cholesterol will be explored more fully in the 
near future.  
 
The role of spheroplasts in mycobacterial infection is still unknown. The use of a Map 
specific probe to determine whether the coccoid forms seen in THP-1 cells are in fact 
Map bacteria will determine whether this avenue of research is viable. 
 
Results presented in this thesis support the hypothesis that Map is able to persist in 
human cells, in compartments enriched with cholesterol, and positive for Rab 7 and 
TACO staining. These elements are seen on phagosomes of related pathogenic 
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mycobacteria. The role of Map in CD continues to be debated. The heterogeneity of 
Crohn’s disease symptoms and pathology suggests that there may be several 
interacting causes, and even several diseases grouped under the CD umbrella. These 
results support the hypothesis that Map may be involved in the aetiology of at least a 
subset of CD cases.  
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Appendix 1 - Ziehl-Neelson (acid fast) stain for mycobacterial visualisation. 
 
1.) Bacteria were heat fixed to a microscope slide 
2.) Slide was flooded with carbolfuchsin (containing 1% basic fuschin (w/v), 10% 
ethanol and 5% phenol) for 2 min. 
3.) Slide was decolourised with acid alcohol (1% HCl in ethanol) 
4.) Slide was counterstained with methylene blue (containing 0.14% methylene 
blue) for 30 seconds. 
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Appendix 2  - Cholesterol standard curve 
 
Substrate was control sera from cholesterol quantitation kit (Roche, Mannheim, 
Germany). The trendline was generated from three representative experiments 
measuring absorbance at 490 nm. 
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R2= 0.9987
y = 0.0033 + 0.0831 
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Appendix 3 - Whole cell lysis buffer for cholesterol extraction 
 
HEPES 20 mM, pH 7.5 
NaCl 0.35 M      
20% glycerol 
1% NP-40 
1 mM MgCl2 
0.5 mM EDTA 
0.1 mM EGTA 
1x protease inhibition tablet (Roche)/50ml solution 
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Appendix 4 - Protein assay 
 
Protein assays were conducted using a published method (Sandermann and Stromiger 
1972).  1 ml of Solution A, was added to eppendorf tubes, and increasing concentrations 
of BSA (up to 25 mg/ml) were added to duplicate standard curve tubes. 10 μl of 
bacterial or cellular lysate from each experimental treatment was added to duplicate 
tubes. Tubes were left for 15 min at room temperature. Then, 100 μl Folins reagent 
(Merck, Darmstadt, Germany) was added, tubes were then vortexed and incubated at 
room temperature for 30 mins. For analysis, 250 μl of sample from each tube was 
aliquoted into wells of a 96 well plate, then read at 660 nm using a spectrophotometer. 
Sample protein was quantitated using a standard curve.    
 
Solution A: Made up in distilled water. 
2 % sodium carbonate  
0.4 % sodium hydroxide 
0.16 % potassium sodium tartrate 
1 % sodium dodecyl sulfate  
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Appendix 5 - Electron microscopy 
 
Sample plugs 
 
Samples were fixed in 2.5 % gluteraldehyde for 1 h at room temperature, washed twice 
in low salt phosphate buffer, then resuspended in 50 μl 3 % agarose solution 
(warm/liquid). The suspension was mixed and aliquoted onto a microscope to set. 
Bacteria/cell rich areas of agarose were cut into 1 mm cubes and transferred to an 
eppendorf tube. 
 
Staining 
 
Plugs were resuspended in 1 % osmium tetroxide solution for 1 h (with gentle spinning), 
then washed three times with low salt phosphate buffer. They were then resuspended in  
urinal acetate solution and incubated at RT for 20 minutes with gentle spinning. 
 
Processing 
 
Plugs were sequentially dehydrated by 5 min washes with increasing concentrations of 
EtOH (50 %, 75 %, 95 %, 100 %, 100%). After the final wash, the plugs were 
resuspended in a mixture of 50 % Spurrs resin and 50 % EtOH (100 %). After 1 h of 
incubation at RT, the resin EtOH mix was replaced with Spurrs resin, and tubes were 
incubated for 1 h at RT. After a further incubation with resin, plug pieces were placed in 
block moulds, which were filled with resin and incubated overnight at 65oC.  
 
Low salt phosphate buffer solution 
 
0.0089 g/ml Na2HPO4.2H20 (pH 7.2 in H2O) 
